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ABSTRACT 
Adenylosuccinate synthetase governs the committed step of AMP biosynthesis from 
IMP: the generation of 6-phosphoryl-IMP from GTP and IMP, followed by the formation of 
adenylosuccinate from 6-phosphoryl-IMP and L-aspartate. Prokaryotes such as Escherichia 
coli (E. coli) have a single form of adenylosuccinate synthetase but vertebrates have two 
isozymes of the synthetase. The basic isozyme, which predominates in muscle, participates 
putatively in the purine nucleotide cycle, has a higher Km for IMP and exhibits substrate 
inhibition by this nucleotide. Compared to E. coli structures, there are conformational 
variations in the IMP pocket both in the ligand-free and IMP-ligated structures of the mouse 
basic isozyme. Furthermore, IMP has alternative modes of binding to the IMP pocket, and 
can also bind to the GTP pocket. GDP- and IMP-ligated complexes of the mouse muscle and 
E. coli systems, which differ only in the type of anion (SO.»2-, Cl~, acetate) or cation (Mg2+ or 
Li*) present in their crystallization milieus, exhibit significant conformational differences in 
active site loops, consistent with the following two rules: i) IMP requires a bound anion to 
the 3-phosphoryl pocket of GTP in order to organize the active site, ii) Mg2+ may bind 
preferentially to an active site ligated by both GDP (or GTP) and IMP, and does not bind as a 
stoichiometric complex of Mg2+/GTP. The feedback inhibitor of the synthetase, AMP, 
depending on the state of active site ligation, behaves as an analogue of IMP or as an 
analogue of adenylosuccinate. The mouse basic isozyme complex of 
adenylosuccinate/GDP/Mg2Vsulfate, reveals significant geometric distortions, tight non-
bonded contacts, and a probable state of protonation for adenylosuccinate consistent with the 
formation of a C-6 purine cation. To a first approximation, adenylosuccinate forms from 6-
phosphoryl-IMP and L-aspartate by the movement of the purine ring into a stationary ex­
amine group of L-aspartate. 
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CHAPTER 1. GENERAL INTRODUCTION 
Role of adenylosuccinate synthetase in purine nucleotide metabolism 
Purine nucleotides are central to most biological processes: they are precursors of 
nucleic acids, components of major coenzymes such as NAD, NADP, FAD, and CoA; they 
play key roles in metabolism and signal transduction. Inhibitors of nucleotide biosynthesis 
are very toxic to cells and their toxicity has been manipulated in the treatment of cancer and 
certain diseases resulting from infections by viruses, bacteria, or protozoans. 
Purine nucleotides can be synthesized either de novo or from the degradation products 
of nucleic acids (salvage pathway). De novo biosynthesis of purine nucleotides (see Fig. 1 ) 
starts with the activation of ribose-5-phosphate into 5-phospho-a-D-ribosyl-l-pyrophosphate 
(PRPP) and continues with the gradual building of the purine base onto the ribose ring, over 
10 reactions. The first nucleotide formed is IMP and, from this point, the pathway branches 
off, in two additional reactions, leading to either AMP or GMP formation. The regulation of 
the whole pathway aims to control the pool of purine nucleotides and balance the relative 
production of AMP and GMP, mainly through the feedback inhibition by the products of the 
pathway, AMP and GMP. or by their corresponding di- and tri-nucleotides. The control 
points are in the beginning of the pathway (at the level of the first two reactions) and, after 
IMP formation, at the level of either adenylosuccinate synthetase or IMP dehydrogenase. 
The formation of AMP from IMP is fueled by GTP hydrolysis, whereas IMP transformation 
into GMP requires ATP. IMP can also be generated by the salvage pathway, from 
hypoxanthine and PRPP, in a reaction catalyzed by hypoxanthine-guanine 
phosphoribosyltransferase. 
The first reaction and the committed step of AMP synthesis from IMP is catalyzed by 
adenylosuccinate synthetase [IMP:L-aspartate ligase (GDP-forming), EC 6.3.4.4] (1). The 
enzyme converts IMP and L-aspartate to adenylosuccinate (SAMP) while hydrolyzing GTP 
in the presence of Mg2>. Adenylosuccinate is further cleaved by adenylosuccinate lyase, to 
fumarate and AMP. Adenylosuccinate synthetase, adenylosuccinate lyase and AMP 
deaminase define the purine nucleotide cycle (PNC) (2), which catalyzes the net reaction: 
L-Aspartate + GTP + HiO -> Fumarate + GDP + Pi + NH3. 
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This cycle takes place in homogenized mammalian tissues such as muscle (2), liver 
(3), brain (4) pancreatic islets (5) and kidney (6). It was proposed to have several putative 
functions: regulation of ATP/ADP ratio, release of ammonia from aspartate, coupling of 
glycolysis with purine nucleotide biosynthesis, providing Krebs cycle intermediates 
(fumarate) in tissues lacking pyruvate carboxylase (1). 
Adenylosuccinate synthetase is present in most organisms, with the exception of 
some intracellular parasitic bacteria (7). The adenylosuccinate synthetases from various 
sources exhibit significant sequence conservation (approximately 40% sequence identity 
between eubacteria and mammals) (8,9). Generally, eukaryotic synthetases have a longer N-
terminus and a slightly shorter C-terminus (8-10). Vertebrates possess two different 
isozymes of the synthetase, differing from each other in isoelectric point, kinetic properties, 
tissue distribution, and regulation (1,8,9,11-15). The basic isozyme (often called the muscle 
enzyme or AdSSl) exhibits substrate inhibition by IMP, has a higher Km for IMP and a lower 
Km for aspartate compared to the acidic isozyme (often called the liver enzyme or AdSS2). 
The acidic isozyme is slightly less inhibited by fructose 1,6-bisphosphate (FI6P2) and more 
potently by nucleotides (11,13). On the basis of these differences, the two isozymes were 
assigned different roles; the basic isozyme to the purine nucleotide cycle and the acidic 
isozyme to de novo biosynthesis (1,13). The tissue distribution of the two isozymes, 
however, is not consistent with mutually exclusive metabolic roles. The basic synthetase is 
the only synthetase present in muscle and heart and the acidic enzyme predominates in 
kidney, brain and spleen (16), in liver both forms exist and the ratio of the two isozymes may 
change with nutritional state. Reportedly, skeletal muscle and heart tissues synthesize 
purines de novo. No compartmentation of the two isozymes has been reported in liver and it 
is not clear how one isozyme would be recruited for a certain function. Hence, the strict 
functional assignment of the two isozymes is not warranted by the data. 
Kinetic and chemical mechanism of adenylosuccinate synthetase 
The kinetic mechanism of the synthetase from E. coli is rapid equilibrium random 
(17). The sequential random binding mechanism has been demonstrated for synthetases from 
numerous sources (16,18). 
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Adenylosuccinate synthetase couples the synthesis of a C-N bond (ligase reaction) to 
the hydrolysis of GTP. This type of reaction occurs in the biosynthesis of purine and 
pyrimidine nucleotides, of some amino acids, and in the urea cycle. Typically in such 
reactions, besides the nucleoside triphosphate, there are two more substrates: a nitrogen 
donor substrate (such as ammonia, giutamine, asparagine, aspartate) and a nitrogen acceptor 
substrate. Several of the enzymes that catalyze C-N ligation, do so in two stages. In the first 
step the nitrogen acceptor' substrate is phosphorylated with the triphosphate nucleoside 
acting as the phosphoryl donor. In the second step the "nitrogen donor' substrate attacks the 
phosphorylated intermediate, forming the product. Some examples of such enzymes include: 
glycinamide ribonucleotide transformylase, GMP synthetase, carbamoyl phosphate 
synthetase, CTP synthetase, giutamine synthetase, argininosuccinate synthetase and ornithine 
transcarbamoylase. Adenylosuccinate synthetase is also a classic example of such an 
enzyme, with IMP as the 'nitrogen acceptor' substrate, L-aspartate as the nitrogen donor' 
substrate and GTP furnishing the phosphoryl group (see below). 
The reaction mechanism of adenylosuccinate synthetase, enjoying the largest 
experimental support, was proposed by Lieberman in 1956 (19): The first step is the 
nucleophilic attack of the 6-oxygen atom of IMP on the ^-phosphorous atom of GTP, 
forming 6-phoshoryl IMP (6PIMP). The second step is the nucleophilic attack of the amino 
group of L-aspartate on the C6 atom of 6PIMP, displacing orthophosphate and forming 
adenylosuccinate. The existence of the phosphorylated intermediate, 6PIMP, is consistent 
with data from positional isotope exchange, isotope exchange at equilibrium and x-ray 
diffraction experiments (20-23). Thus, the O18 P-y bridging oxygen of GTP exchanged into 
the terminal oxygens of ^-phosphoryl group only when IMP was present (20). At 
equilibrium, GTP exchanges with GDP and Pi and IMP exchanges with SAMP at 
comparable rates, which are 10-fold slower than the exchange rate of L-aspartate and SAMP 
(22). The isotope exchange data suggested a forward binding mechanism with a preferred 
path in which the quaternary complex is most frequently formed by L-aspartate binding to 
the E-GTP-IMP complex (i.e. E-6PIMP-GDP complex). Furthermore, the lack of partial 
exchange between aspartate and adenylosuccinate, in the presence or absence of Pi, 
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suggested that 6PIMP intermediate is tightly bound to the enzyme (22). Finally, in crystal 
structures of E. coli synthetase 6PIMP is trapped at the active site (23). 
Substrate specificity of adenylosuccinate synthetase 
The synthetase is rather specific for its substrates, as expected for an enzyme at a 
regulatory point in the purine metabolism. Hydroxy lamine, L-alanosine, ^-cysteine sulfinate, 
alanine-3-nitronate and DL-threo-|3-fluoroaspartate can substitute for L-aspartate (19,24-26). 
GTP analogs that sustain synthetase activity include GTPyS (27) and 2-deoxy GTP (12). 
The latter compound, as determined in the case of rabbit skeletal muscle synthetase, has a 
much higher Km than that of GTP but can achieve the same maximal activity (12). On the 
other hand, for the same system, 2-deoxy IMP has the same Km as IMP but sustains about 
half-maximal activity (28). However, in a recent study done on three different synthetases 
(recombinant basic and acidic mouse isozymes as well as E. coli synthetase) by T. Borza and 
H. J. Fromm (manuscript in preparation), it was shown that 2-deoxy IMP increases the Km 
for L-aspartate by 20- to 40-fold. Under conditions of saturating L-aspartate, 2'-deoxy IMP 
can support the same maximal activity as IMP, although it would require high concentrations 
of L-aspartate. Interestingly, the basic isozyme, which has a lower Km for L-aspartate than 
its acidic counterpart, can use 2'-deoxy IMP as a substrate at physiological concentrations of 
L-aspartate. Therefore, the basic isozyme (but not the acidic isozyme) could participate in 
the salvage pathway that recycles deoxy-nucleotides coming from DNA degradation. Other 
analogs that can substitute for IMP are (3-arabinosyl IMP and compounds in which one 
oxygen from the 5'-phosphoryl group is replaced with N, S and C atoms (28,29). |3-
arabinosyl IMP has a higher Km than IMP and, like 2'-deoxy IMP, reportedly has only 50% 
maximal activity (28). Given the above findings regarding 2-deoxy IMP, however, the 
lower maximal activity may come from insufficient L-aspartate concentrations used in 
assays. The enzymes from Leishmania donovani and Trypanosoma cruzi have an unusual 
specificity compared to the mammalian enzymes. They can use as substrates 8-aza-IMP and 
allopurinol ribonucleotide, IMP analogs that are weak inhibitors for the mammalian enzymes 
(30,31). In these protozoa, allopurinol ribonucleotide is transformed by the action of the 
synthetase and lyase into an AMP analog that ends up in the RNA. As the allopurinol 
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ribonucleotide is not accepted by the mammalian synthetases as substrate, it can function as 
an antileishmanial agent. 
The synthetase requires a divalent cation for activity and magnesium is the best 
activator. Mn2* and Ca2+ can also substitute for Mg2+ but with decreased activity (1,8,13,32). 
It has been proposed that Mg2+ binds to the enzyme as a GTP-Mg2+ complex and not as a 
separate substrate. Recent studies done by T. Borza and H. J. Fromm (unpublished) revealed 
that the recombinant mouse acidic and basic isozymes have different affinity for the 
activating metal: The acidic enzyme has a higher affinity for Mg2+, Mn2+ and Ca2+. 
Concentrations higher than 10 mM magnesium salt inhibit the synthetase and the counterion 
to magensium is important as it can further inhibit the enzyme (discussed below). 
Inhibitors of adenylosuccinate synthetase 
Adenylosuccinate synthetase is potentially a target of a natural herbicide (34) and of a 
drug used in the treatment of pediatric leukemia (35). The synthetase is subject to feedback 
and product inhibition by AMP, XMP, GMP, GDP and SAMP (1,11-14,28,.36-37). Usually 
competitive inhibitors with respect to IMP have lower Kx values for the acidic isozyme than 
for the basic one; this behavior being well correlated with the difference in the Km for IMP 
for the two isozymes. K\ values for AMP range from 47 to 170 p.M, usually AMP was shown 
to be competitive with respect to IMP although a noncompetitive pattern was reported for the 
synthetase from Novikoff ascites tumor cells (36). Recent studies done on the mouse 
recombinant isozymes have shown differences both in the potency and kinetic mechanism of 
AMP inhibition (33). Thus, K\ for AMP is 12-fold higher for the basic isozyme (700 ^iM) 
and the inhibition is competitive with respect to IMP in the acidic isozyme but 
noncompeti t ive with IMP in the basic isozyme .  AMP inhibit ion of the acidic isozyme (K\ 
=60 |iM) is probably physiologically relevant. 
XMP competes with IMP and has a AT; comparable to that of AMP (14,36). SAMP is 
a competitive inhibitor with respect to IMP, with Kt values close to or sometimes lower than 
the Km of IMP (5-54 |iM) (14,33). An analog of SAMP and one of the most potent 
competitive inhibitors of the synthetase with respect to IMP is L-alanosyl-5-amino-4-
imidazolecarboxylic acid ribonucleotide (alanosyl-AICOR, K\=Q2 pM, 38). This compound 
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is produced by another enzyme involved in de novo biosynthesis of purine nucleotides, 5-
amino-4-imidazole-N-succinocarboxamide ribonucleotide synthetase when using alanosine 
as a substrate, instead of L-aspartate. Alanosine is excreted by Streptomyces alanosinicus 
and has antibiotic, antitumor and immunosuppressive activity (24). Although an analog of L-
aspartate, alanosine itself has no significant direct effect on the synthetase (24). Another 
strong inhibitor of the synthetase is the IMP analog hydantocidin 5'-phosphate which has K\ 
values of 10 nM (39). 
6-mercaptopurine ribonucleotide is competitive with IMP, with a K, of 44 pM for the 
synthetase from Novikoff ascites tumors (37) but with K\ values ranging from 400 to 700 pM 
for the basic isozyme from rabbit muscle (28). This compound is an important drug that 
inhibits various nucleotide metabolizing enzymes. 
K\ values for GMP and GDP are comparable to the Km values for GTP and range from 
7 to 45 p.M (1,14,37). GMP primarily competes with GTP but, at high concentrations, can 
also bind at the IMP site (14). The 2'-deoxy versions of GDP and GMP also inhibit the 
synthetase, though their Kx values are about twice higher than those of their unmodified 
ribose (14,28). Other GMP analogs that compete with GTP as efficiently as GMP are 8-aza 
GMP and 7-deaza-8-deaza GMP (28). P-D-arabinosyl GMP, similarly to 2'-deoxy GMP, has 
a K\ value about 2.5 fold higher than that of GMP (28). Guanosine 5-diphosphate s -
diphosphate (ppGpp), whose concentrations increase significantly under conditions of 
stringent response in £. coli, is another potent inhibitor of the syntetase (#=50 ^M,40-41). 
Competitive inhibitors with respect to L-aspartate, as determined for the synthetase from 
Azotobacter vinelandii are succinate (Ki=1.8 mM), oxaloacetate (Ki=0.5 mM), malonate 
(Ki=0.9 mM), phosphoenolpyruvate (Ki=0.2mM) (42). However, recent studies done on the 
£. coli enzyme showed some of these inhibitors to be less effective (43). Fumarate is not an 
inhibitor of the synthetase indicating that L-aspartate probably binds in the cis configuration. 
The most potent inhibitor with respect to L-aspartate known to date is hadacidin (N-formyl-
N-hydroxyaminoacetic acid), a natural antibiotic isolated from the fermentation product of 
Pénicillium frequentans (44), with a AT, of 0.3-6.3 ^M (42,37). 
A possible physiological inhibitor of the synthetase is fructose-1,6-bisphosphate 
(FI6P2). The inhibition by this glycolytic intermediate is noncompetitive with respect to all 
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substrates (45). The acidic isozyme is generally less inhibited by FI6P2 than the basic 
isozyme (1,11). For the basic isozyme, K\ values for FI6P2 range from 50 to 130 nM 
(1,16,46) and, as FI6P2 concentrations can reach 80 ^M in muscle, FI6P2 inhibition of the 
basic isozyme could be physiologically relevant. 
The synthetase is also inhibited by some anions, including NO3", SCN", Cl , I , Br and 
HCO3" (12,42, 46). NO3 was shown to be a synergistic inhibitor with respect to GDP (42), 
by binding at the y-phosphoryl group site of GTP. CI seems to behave in the same way (46). 
For the rabbit muscle synthetase it was shown that Pi is a noncompetitive inhibitor with 
respect to IMP, GTP and L-aspartate with Ki values of 17 mM, 12 mM and 42 mM, 
respectively (12). Sulfate also inhibits the synthetase, probably mimicking the effect of Pi. 
Thus, at 25 mM Na2SC>4 or (NHthSQj the synthetase isolated from rabbit skeletal muscle has 
only 30% activity (12). 
Structures of adenylosuccinate synthetase 
Adenylosuccinate synthetase crystallizes as a dimer. In solution, £. coli 
adenylosuccinate synthetase is in a monomer-dimer equilibrium with a K& of about 10 nM 
(47). However, in the presence of the active site ligands, the equilibrium is significantly 
shifted towards the dimer (47). Furthermore, it has been shown that the active species is the 
dimer (48). Recent studies on the mouse isozymes confirmed the existence of the monomer-
dimer equilibrium in these systems as well, however, the dimer is much more stable than for 
the £. coli enzyme (33). Crystal structures of the recombinant adenylosuccinate synthetases 
from £. coli, and plants (Arabidopsis Thaliana and Triticum Aestivum (49-61) are available. 
In conformity with the high degree of sequence conservation, the overall polypeptide fold of 
the above synthetases is similar and consists of a central lO-stranded P-sheet flanked by a-
helices and loops (61). 
The first synthetase extensively studied by X-ray crystallography was the £. coli 
enzyme. Structures of the ligand-free (49,50), partially ligated (52,55,59,60) and fully 
ligated (51,53,54,56,58) complexes of £. coli helped define the structural elements involved 
in substrate recognition and active site organization for catalysis as well as the mechanistic 
details of the synthetase. Among the ligands explored in structural studies of the £. coli 
8 
adenylosuccinate synthetase are: IMP, GTP, GDP, Mg2*, Ca2+, Pi, sulfate, AMP, 6-thio IMP, 
hydantocidin 5*-monophosphate, hadacidin, a bisubstrate analog combining hydantocidin and 
hadacidin, and guanine nucleotide analogs (GppNp, GppCp, ppGpp) (51-60). L-aspartate 
has never been observed in crystal structures of the synthetase, although it was included in 
crystallization conditions in a variety of complexes. Thus, the L-aspartate analog that is 
routinely used in crystallization is hadacidin. 
Four loops at the active site exhibit significant conformational changes upon ligand 
binding: the Switch loop (residues 38-53), the IMP loop (residues 120-130), the Asp loop 
(residues 299-304) and the GTP loop (residues 417-421). The conformation of these 
structural elements in structures of the fully ligated complexes define the "ligated' state 
whereas the ligand-free structures define the "unligated' state of these loops. Figure 2 
presents a superposition of the unligated and fully ligated structures, showing the 
conformational variation in the active site loops. Figure 3 shows the relevant interactions 
between the protein and a full set of ligands: 6PIMP, Mg2+, GDP and hadacidin. Residues 
belonging to dynamic structural elements are underlined. 
Dynamic elements of the active site 
The Switch loop undergoes the largest conformational change (up to 9 Â) and its 
ligated' position is a mark of catalytic readiness, as residues of this loop (Asn38, Gly40, 
His41, Thr42) interact with 6PIMP (or IMP), Mg2> and GDP (or GTP). In the unligated state 
of the loop, His41 makes a salt link with Asp21, whereas in a ligated active site, this 
interaction is disrupted and Asp21 forms a salt link with Arg419, a residue belonging to the 
GTP loop. 
The IMP loop is disordered in the ligand-free structures or in partially ligated 
structures lacking IMP or an IMP analog. A conserved threonine residue (Thrl29) from the 
C-terminal part of this loop interacts with the 5'-phosphoryl group of IMP. This interaction 
promotes a well defined conformation for the backbone of the C-terminal residues of the IMP 
loop (residues 126-129); the hydrogen bond interactions of the backbone amides of these 
residues with the side chain of Glu 118, a conserved residue from the N-terminal part of the 
IMP loop, are essential in ordering the entire IMP loop. 
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The Asp loop is disordered in the unligated structure and, at best, poorly ordered in 
partially ligated structures that do not include hadacidin. This loop contains residues that 
putatively recognize the fi-carboxyl group of L-aspartate (residues: Val299, Thr300, Thr301, 
Arg303). 
GTP loop contains residues (418-419) that pack against the base of the guanine 
nucleotide. The ligated state of this loop involves a rigid-body shift from its unligated 
position, towards the Switch loop. 
Substrate induced conformational changes 
Cocrystallization of the £. coli synthetase with GTP or GDP was unsuccessful, 
however soaks of the guanine nucleotide analogs guanosine-5'-(beta,gamma-imido) 
triphosphate (GppNp) and guanosine-5'-phosphate-(beta,gamma-methylene) triphosphate 
(GppCp) in crystals of the ligand-free enzyme revealed the binding of these compounds to 
the active site with a minimum of perturbation; only the GTP loop moved into its ligated 
position (52). However, cocrystallization of the enzyme with IMP produced crystal 
structures of the synthetase with a fully organized active site: IMP, GTP, and Switch loops in 
their ligated positions (59). The Asp loop, although in its ligated position, had a higher 
degree of flexibility as indicated by its thermal parameters. These structures have led to the 
suggestion that IMP alone can organize the active site of the synthetase and that the lack of 
response to GTP binding is part of the enzyme's strategy to avoid unnecessary GTP 
hydrolysis in the absence of the phosphate acceptor (IMP). The interaction of Asn38 with 
the 5'-phosphoryl group of IMP was proposed to leverage the movement of the Switch loop 
from the unligated to the ligated position (8,59). Mutations of Asn38 to alanine or glutamate, 
significantly decreased the Ârcat of the enzyme, while having almost no effect on the Km for 
IMP, supporting the proposed mechanism of ligand-induced fit (62). IMP competitive 
inhibitors, such as AMP, also produce organized active sites, consistent with the fulfillment 
of the 5-phosphoryl group-Asn38 interaction (55). 
Adenylosuccinate synthetase from either Arabidopsis Thaliana or Triticum Aestivum 
was cocrystallized with GDP. The resulting structures had the Switch and GTP loops of the 
active site in the ligated position (61). The implication was that the guanine nucleotides could 
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also pre-organize the active site of the synthetase. However, it was not clear whether this 
would be a general feature of the enzyme or if it was a peculiarity of the plant synthetase. 
The Switch loop of the plant synthetases contains a specific Tyr residue, which forms a 
hydrogen bond with the ribose of GDP. This interaction may be an alternative pathway of 
moving the Switch loop into the ligated position but this would be specific to the plant 
enzyme. 
Structural aspects of the synthetase catalytic mechanism 
Fully ligated complexes of the £. coli synthetase provided structural details of the 
enzyme's chemical mechanism. Thus, the structure of £. coli enzyme ligated with IMP, 
NO3", GDP, hadacidin and Mg2+ provided a model for the transition state of the first step of 
the reaction: the formation of 6PIMP (51). The second step of the reaction was modeled on 
the basis of the crystal structure of the enzyme complexed with 6PIMP (or 6SIMP), GDP, 
hadacidin and Mg2+ (53,56). From these studies, the important catalytic roles played by 
Asp 13, His41, Gln224 and magnesium was evident. Thus, in the first step of the reaction 
Asp 13 abstracts the proton from N1 atom of IMP, thus making the 06 atom of IMP a better 
nucleophile. His41 stabilizes the negative charge of one of the oxygen atoms of the (3-
phosphoryl group of GTP, whereas Gln224 stabilizes the developing negative charge on the 
06 atom of IMP. 06 attacks the y-phosphorus atom of GTP, GDP becomes the leaving 
group and 6PIMP is formed. At this stage His41 reorients and interacts with the 6-
phosphoryl group of 6PIMP while Asp 13 enters in the coordination sphere of Mg2+. For the 
second part of the reaction, L-aspartate was modeled based on how hadacidin binds to the 
active site. Thus, in the second step of the reaction the correct orientation of the attacking 
amino group of L-aspartate with respect to 6PIMP would be assisted by the carbonyl of 
Asn38 and one oxygen of the (3-carboxylate group of aspartate. The importance of Asp 13, 
His4l and Gln224 in the catalytic mechanism has been confirmed by mutagenesis studies 
(63,64). Thus, mutation of the catalytic Asp 13 to Ala results in an inactive enzyme whereas 
mutations of His41 or Gln224 significantly decrease the £cat. 
Generally, the £. coli structures should provide a good model for the synthetase, as 
expected from the high degree of sequence conservation between prokaryotic and eukaryotic 
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synthetases. However, there are functional differences within the synthetase family, 
particularly regarding the mammalian isozymes, which can not be readily explained by the 
structural model of the £. coli enzyme. For instance, compared to either the £. coli or the 
acidic enzymes, the basic isozyme is less susceptible to AMP inhibition, has one of the 
lowest Kms for L-aspartate, has a higher Km for IMP and exhibits substrate inhibition by this 
nucleotide. The £. coli synthetase has an acidic pi, similar to the acidic isozyme from 
vertebrates, and shares common kinetic properties. However, the acidic isozyme has the 
highest Km for L-aspartate in the synthetase family. Allopurinol ribonucleotide is a substrate 
for the synthetase from prokaryotes such as Leishmania donovani and Trypanosoma cruzi, 
but is at best a weak inhibitor of the mammalian synthetases, thus making allopurinol an 
antileishmanial agent. Truncations of the longer N-termini of both isozymes did not alter 
kinetic properties (33). Therefore, the functional variance of the two isozymes arises from the 
core sequence, common also to £. coli synthetase, in which the two isozymes share over 70% 
sequence identity. 
As most residues involved in substrate binding are conserved within the synthetase 
family, the variability in substrate specificity and affinity is not readily explicable. However, 
residues making up the dynamic elements of the active site (Switch, IMP, GTP, and Asp 
loops) may vary. Therefore, different ligand-induced fit mechanisms may be responsible for 
the functional diversity within the synthetase family. 
Structural studies on mammalian synthetases would not only contribute to a better 
understanding of adenylosuccinate synthetase, but would also aid in drug design by revealing 
differences between prokaryotic and mammalian synthetases. 
Dissertation Organization 
This dissertation is organized in six chapters. Chapter 1 is a general introduction on 
the properties of adenylosuccinate synthetase. Chapters 2 and 3 are papers published in peer 
reviewed journals. Chapter 4 is a paper that has been submitted for publication in Journal of 
Biological Chemistry. All these chapters present crystal structures of the mouse basic 
adenylosuccinate synthetase: the unligated structure is the object of Chapter 2, substrate 
complexes are discussed in Chapter 3, whereas Chapter 4 presents the product complexes. 
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Chapter 5 is a manuscript that will be submitted to a scientific journal. In this chapter, 
partially ligated structures of both £. coli and mouse basic adenylosuccinate synthetase are 
presented. Chapter 6 contains the general conclusions of this dissertation. 
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Figure 1. Purine nucleotides biosynthesis. IMP represents the branching point in AMP and GMP synthesis. 
IMP can be generated either by de novo pathway or by the salvage pathway.. Adenylosuccinate synthetase 
catalyzes the first committed step of AMP biosynthesis from IMP. 
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6PIM 
Switch 
loop 
Figure 2. One monomer of E. coli adenylosuccinate synthetase in a fully ligated complex 
(PDB ID 1CG0, 23), viewed towards the active site. The dynamic loops of the active site: 
the Switch (residues 38-53), the IMP (residues 120-130), the Asp (residues 298-304) and the 
GTP (residues 417-421) loops are shown in their unligated (dark gray) and ligated (light 
gray) conformations. The active site ligands: 6PIMP, GDP, Mg2+~ and Hadacidin (labeled 
HAD) are drawn as ball and sticks. 
17 
G416 
P417 
H41 » 
6PIMP 
R143# 
G416 
P417 
R303 / 
6PIMP 
•T239 
R143# 
Figure 3. Stereo view of the active site of E. coli synthetase fully ligated complex (PDB 
ID IGIN, 23). Dashed lines represent hydrogen bond interactions or coordinate bonds to 
Mg2+. The ligands: 6PIMP, GDP, Hadacidin (HAD) and Mg2+ are shown with thicker lines 
whereas the protein residues are drawn with thinner lines. 
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CHAPTER 2. RECOMBINANT MOUSE-MUSCLE 
ADENYLOSUCCINATE SYNTHETASE: OVER EXPRESSION, 
KINETICS, CRYSTAL STRUCTURE 2 
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Cristina V. Iancu3, Tudor Borza3, Jun Yong Choe, Herbert J. Fromm, and Richard B. 
Honzatko4 
Abstract 
Vertebrates possess two isozymes of adenylosuccinate synthetase. The acidic 
isozyme is similar to the synthetase from bacteria and plants, being involved in the de novo 
biosynthesis of AMP, whereas the basic isozyme participates in the purine nucleotide cycle. 
Reported here is the first instance of over expression and crystal structure determination of a 
basic isozyme of adenylosuccinate synthetase. The recombinant mouse-muscle enzyme, 
purified to homogeneity in milligram quantities, exhibits a specific activity comparable to 
that of the rat-muscle enzyme isolated from tissue, and Km parameters for GTP, IMP, and L-
aspartate (12 nM, 45 nM and 140 |iM, respectively) similar to those of the enzyme from 
Escherichia coli. The mouse-muscle and E. colt enzymes have similar polypeptide folds, 
differing primarily in the conformation of loops, involved in substrate recognition and 
stabilization of the transition state. Residues 65—68 of the muscle isozyme adopt a 
conformation not observed in any previous synthetase structure. In its new conformation, 
segment 65—68 forms intramolecular hydrogen bonds with residues essential for the 
recognition of IMP, and in fact, sterically excludes IMP from the active site. Observed 
differences in ligand recognition amongst adenylosuccinate synthetases may be due in part to 
conformational variations in the IMP pocket of the ligand-free enzymes. 
Introduction 
Adenylosuccinate synthetase [IMP: L-aspartate ligase (GDP-forming), EC 6.3.4.4] 
catalyzes the first committed step in the de novo biosynthesis of AMP. In vertebrates the 
synthetase is also a component of the purine nucleotide cycle, which inter-converts IMP and 
AMP (1-3). Adenylosuccinate synthetases from various sources exhibit significant sequence 
conservation [approximately 40% sequence identity between eubacteria and mammals, for 
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instance (4)]. Nonetheless, synthetases from nearly every eukaryotic organism have 
approximately 30-residues added to their N-termini and truncations at their C-termini relative 
to the bacterial synthetases. Moreover, vertebrates express two distinct forms of 
adenylosuccinate synthetase (5). The basic isozyme (often called the muscle enzyme or 
AdSSl) is associated with the purine nucleotide cycle (1), whereas the acidic isozyme (often 
called the liver enzyme or AdSS2) is associated with de novo biosynthesis of AMP (5). The 
two isozymes differ not only in their isoelectric points, but may differ also in their kinetic 
properties, regulation and tissue distribution (2,3). 
Adenylosuccinate synthetase from Escherichia coli is the most studied of all 
synthetases. Its kinetic mechanism is rapid-equilibrium random (6). 6-Phosphoryl-IMP is an 
intermediate in a two-step process that begins with the transfer of the y-phosphoryl group of 
GTP to the 6-keto group of IMP, followed by the displacement of Pi from the intermediate by 
L-aspartate to form adenylosuccinate (7-11). In the absence of ligands the synthetase from £. 
coli is an equilibrium mixture of monomers and dimers (7,12). Active-site ligands and/or 
high subunit concentrations favor dimer formation. Hence, crystallization experiments have 
thus far resulted only in dimer assemblies (9-11,13-19). IMP alone may stabilize the 
synthetase dimer, and by itself triggers conformational changes in the active site of the £. 
coli synthetase (Hou, Z„ Fromm, H. J., and Honzatko, R. B, unpublished). Recent structures 
of the synthetase from plants, Arabidopsis thaliana and Triticum aestivum, reveal, however, 
organized active sites in the presence of GDP alone (19). 
More than two decades ago, the basic isozymes from rabbit (20) and rat (21) were 
purified and characterized. Subsequent studies confirmed a random-sequential kinetic 
mechanism for these muscle synthetases (6,8). Several groups reported crystals of the basic 
isozyme (20, 21), as well as preliminary X-ray diffraction data (22), but no structure of the 
basic isozyme has appeared in the literature. Only the cDNA encoding the mouse-muscle 
isozyme has been cloned (4). Reported here are first instances of heterologous over-
expression and structure determination of the basic isozyme of adenylosuccinate synthetase. 
The enzyme is expressed in £. coli using an N-terminal, polyhistidyl tag to facilitate 
purification. The purified enzyme crystallizes readily in the absence of ligands. The 
resulting crystal structure of the ligand-free protein at 2.5 À resolution, reveals a polypeptide 
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fold similar to those of synthetases from £. coli and plants. The active sites of the basic 
isozyme and the £. coli synthetase, however, differ significantly in the conformation of 
loops, which define, in part, the IMP and GTP binding sites. Indeed, the basic isozyme, as 
seen here, cannot bind IMP as does the £. coli synthetase without a conformational change 
involving residues that up to now have been conformational^ invariant amongst all known 
synthetase structures. 
Experimental Procedures 
Materials— Restriction enzymes, DNA ligase and Vent Polymerase came from New 
England Biolabs. Plasmid pET28b, £. coli strain BL21 (DE3), and the thrombin cleavage 
capture kit were from Novagen, Inc. Ni-NTA agarose was from Qiagen. All other reagents, 
including GTP, IMP, L-aspartate, bovine serum albumin, and DEAE-Sepharose, were from 
Sigma unless noted otherwise. 
Construction of pAdSSla Expression Plasmid— cDNA for mouse muscle adenylosuccinate 
synthetase (AdSS I) was kindly provided by Dr. F. B. Rudolph (Department of Biochemistry 
and Cell Biology, Rice University, Houston TX) as a pBluescript SK clone (4). A fragment 
of 1351 base pairs was amplified using the following primers: forward, 5'-
CCCTTGTCATATGTCCGGGACCCGAGCCTC-3 ' (Nde I restriction site underlined) and 
reverse, 5-CCGCTCGAGAAAAAGCTGGATCATGGACTCTC-3' (Xho I restriction site 
underlined). Insertion of the amplified fragment into corresponding sites of the pET28b 
expression vector resulted in the plasmid pAdSSla. 
Expression and Purification of the Recombinant Muscle Isozyme— Protein was expressed in 
£. coli BL21 (DE3), grown at 37°C in LB media containing 50 |a.g/ml kanamycin. After the 
cell culture reached an ODeoo of 1.4, IPTG was added to a final concentration of 0.3 mM and 
the culture was maintained at 15°C overnight. Cells were collected at 4000 x g for 10 min. at 
4°C. Harvested cells were disrupted by sonication in lysis buffer (50 mM NaHiPO^ 300 
mM NaCl, 10 mM imidazole, 10% glycerol, pH 8). After centrifugation at 20,000 x g for 30 
min., sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of samples 
from both the supernatant and pellet revealed the production of a protein (~52 kDa), which 
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accounted for approximately 10 % of the total protein. Most of the protein, however, was in 
inclusion bodies. 
The supernatant solution was loaded onto a Ni-NTA agarose column, previously 
equilibrated with 50 mM NaHaPO,», 300 mM NaCl, 10 mM imidazole, pH 8. The column 
was washed sequentially with two buffers (10 volumes of each), differing from that above 
only in the concentrations of imidazole (first 20 mM and then 30 mM). An imidazole 
concentration of 300 mM eluted the target protein. After dialysis in 50 mM Hepes, 50 mM 
NaCl, 1 mM dithiothreitol (DTT) and 0.5 mM EDTA, pH 7.5, the enzyme was loaded at 0.5 
mL/min. onto a DEAE-Sepharose column, equilibrated with the dialysis buffer. At pH 7.5 
all contaminating proteins bind to the resin, whereas the recombinant muscle isozyme elutes 
with the void volume. Sodium dodecylsulfate-polyacrylamide gel electrophoresis of 30 |ig 
of the His-tagged protein revealed no additional bands of protein. The recombinant protein 
can be frozen at -80°C and thawed in the dialysis buffer without any significant loss of 
activity. The His-tag was removed as described in the protocol of the thrombin cleavage 
capture kit. The recombinant protein, with and without the His-tag, was used in subsequent 
kinetics and crystallization experiments. 
Enzyme Assay— Protein concentration was determined by the method of Bradford (23), 
using bovine serum albumin as a standard. Enzyme activity was determined at an 
absorbance of 280 nm and 22°C as described previously (24). The assay buffer contained 20 
mM Hepes (pH 7.2) and 8 mM magnesium acetate. Using up to 1 |ig/ml enzyme, the 
reaction was linear for 1 min. Km and Wmax values for each substrate were obtained by 
holding the other two substrates at saturating levels (100 pM for GTP, 300 |iM for IMP, and 
2000 gM for L-aspartate) and varying the third substrate. GTP was varied from 5 to 100 p.M, 
IMP from 25 4M to 500 (J.M and L-aspartate from 100 |iM to 1000 4M. All kinetic data 
were analyzed with the computer program ENZFITTER (25). 
Crystallization— Crystals were grown by the method of hanging drops. Equal parts of a 
protein solution (10 mg/mL of protein in 50 mM Hepes pH 7.5, 50 mM NaCl, 1 mM 
dithiothreitol, 0.5 mM EDTA) and precipitant solution (200 mM calcium acetate, 100 mM 
cacodylate pH 6.5, 18% polyethylene glycol 8000) were combined in 4 |iL droplets. The 
wells contained 500 |iL of the precipitant solution. Equal-dimensional prisms of 100 
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microns appeared within 3 days at 22°C. Crystals were transferred in three steps (10-minute 
intervals) to solutions, containing 100 mM calcium acetate, SO mM cacodylate (pH 6.5), 19% 
(w/v) polyethylene glycol 8000 and glycerol at 7, 14, and 21% (v/v), and then frozen in 
liquid nitrogen. 
Data Collection, Model Building and Refinement—Data were collected at Beamline 9-2 of 
Stanford Synchrotron Radiation Laboratory (SSRL), using the CCD detector, ADSC 
Quantum 4. The wavelength of X-radiation was 0.979 Â, and the temperature of data 
collection was 120 K. Data reduction was done with Denzo/Scalepack package (26). The 
structure was solved by molecular replacement with the program AmoRe (27). The initial 
model was the £. coli synthetase [PDB identifier 1SON (18)]. Model building and 
refinement employed the programs XTALVIEW (28) and CNS (29), respectively. Force 
constants and parameters of stereochemistry came from Engh and Huber (30). Individual B-
parameters were refined subject to the following restraints: nearest neighbor, main chain 
atoms, 1.5 Â2; next-to-nearest neighbor, side chain atoms, 2.0 Â2; nearest neighbor, side chain 
atoms, 2.0 Â2; and next-to-nearest neighbor, side chain atoms, 2.5 Â2. Minimum and 
maximum allowable B-parameters were 5 and 100 Â2, respectively. Criteria for the addition 
of water molecules were identical to those of previous studies (9-11). Estimates of 
coordinate error used the method of Luzzati (31). Evaluation of stereochemistry of the 
refined model employed PROCHECK (32). Superposition of structures employed software 
from the CCP4 package (33). Calculations of accessible surface area employed CNS (29), 
using the approach of Lee and Richards (34) and a probe radius of 1.4 À. 
Results and Discussion 
Enzyme Characterization— Previous studies of the rat and rabbit muscle isozymes, isolated 
from tissue reported a high Km for IMP and a low Km for L-aspartate relative to the acidic 
isozymes (5,20,21,35). Largely because of these findings, the basic and acidic isozymes 
were cast as integral components of the purine nucleotide cycle and de novo AMP 
biosynthesis, respectively (5,35). The Km values for GTP, IMP and L-aspartate of the 
recombinant mouse-muscle isozyme are 12±2,45+7 and 140±15 pM, respectively, which are 
more similar to those of the £. coli synthetase [20—50, 20—60 and 200—350 (iM, 
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respectively (36-38)], than values reported for other muscle isozymes isolated from tissue 
[10—120, 107—700 and 250—330 nM, respectively (5,20,21,35,39)]. The relatively large 
range in reported Km values for the synthetase is probably due in part to technical difficulties 
in establishing linear progress curves. GDP is a potent, product inhibitor of all known 
adenylosuccinate synthetases (2), and greatly limits the linear range of progress curves in the 
determination of Km for GTP. Furthermore, the synthetase may exist as a mixture of 
monomers and dimers, governed by an equilibrium constant sensitive to substrate 
concentration (12). Hence, even the oligomeric state of the synthetase may change with 
substrate concentration at a fixed enzyme concentration. The highest values for Km come 
from single-point, stopped assays (5,21), which in addition to the complications noted above, 
provide no information by which to assess the linearity of the progress curve. Excluding 
determinations based on single point assays, the Km values for enzymes from rabbit and rat 
muscle are 10-24, 107-320, and 290-300, respectively (20,35,39,40), for GTP, IMP and L-
aspartate, values approximately twofold higher than those reported here for the recombinant 
enzyme from mouse muscle. 
The recombinant mouse-muscle isozyme has almost the same specific activity as the 
rat muscle enzyme [5.74 versus 6.24 nmoles/min/mg (21)], and is approximately five times 
more active than the protein isolated from rabbit muscle [1.0 nmole/min/mg (41)]. We 
observe no evidence of substrate inhibition for IMP up to a maximum concentration of 500 
HM. Furthermore, thrombin cleavage of the His-tagged synthetase, and subsequent 
purification, does not alter the kinetic parameters of the recombinant enzyme. In fact, the 
thrombin-cleaved protein forms crystals isomorphous to those described below, with a 
structure identical to within experimental uncertainty. 
Structural Features of the Muscle Isozyme—Crystals of ligand-free, mouse-muscle enzyme 
diffract to a resolution (2.5 À) comparable to crystalline synthetases from other sources. The 
space group and unit cell dimensions are virtually identical to those reported for the rat-
muscle isozyme (22). Statistics of data collection and refinement are in Table 1. The 
stereochemistry of the refined model, as analyzed by the program PROCHECK (32), exceeds 
that typically observed for a structure of 2.5 Â resolution. No residues lie in disallowed 
regions of the Ramachandran plot, and 87% of all the residues are in the most favored 
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regions. The average uncertainty in coordinates is approximately 0.3 À. Thermal parameters 
vary from 16 to 100 Â2, the later being an upper limit imposed by the software. 
We observe reliable electron density beginning with residue 26. Hence, the first 25 
residues plus the His-tag construct are disordered and not included as part of the model. The 
His-tag/leader element (approximately 50 residues) is presumably intact, given the successful 
isolation of the recombinant protein from Ni-NTA agarose and the lack of any evidence for 
heterogeneity (by gel electrophoresis) in the purified protein after one week of storage at 
room temperature. The observed starting position in the electron density precedes the 
beginning of the £. coli sequence and structure by five amino acid residues. The trace 
through these initial five residues follows a path different from that of the plant synthetases 
(Fig. 1). Electron density is weak or missing for residues 151—164, which correspond to 
residues 120—130 of the £. coli synthetase. Corresponding residues from plant synthetases 
are disordered as well in the absence of bound IMP. Loop 120—131 of the £. coli synthetase 
becomes ordered, however, upon ligation of the active site (9). 
As expected from the high level of sequence identity (Fig. 2), the overall fold of the 
mouse muscle synthetase is almost identical to that of other synthetases (Fig. 1). The 
structure consists of a 3-sheet core made up of 9 parallel strands (B14, B10, B7, Bl, B6, B2, 
B3, B4, B5) and one antiparallel strand (B15). The core P-sheet is flanked by subdomains 
that contain 11 a-helices, 7 antiparallel (3-strands and five 3m helices. 
Secondary structures of the mouse-muscle, £. coli and plant synthetases are in agreement, 
with only a few differences. Residues 393—398 of the ligand-free, mouse-muscle isozyme 
form a single-turn, 3io-helix, similar in conformation to the corresponding residues of the 
ligated synthetase from £. coli and the plant synthetases, but different from that of the ligand-
free enzyme from £. coli. Loop 330—336 of the mouse-muscle enzyme is in an ordered 
conformation, whereas the corresponding segment (loop 298—304) of ligand-free £. coli 
enzyme is disordered. Hydrogen bonds, involving backbone carbonyls 333 and 334 with the 
side chains of Ser428, Arg43' and Asn435 of a lattice neighbor, may stabilize the conformation 
of the loop 330—336 of the muscle synthetase. In crystal structures of the plant synthetases, 
the corresponding loops are also involved in lattice contacts, despite differences in space 
groups (P4i2i2 for T. aestivum and 123 for A. thaliana). 
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Subunit Interface of the Dimer— The molecular twofold axis of the mouse-muscle synthetase 
coincides with a crystallographic twofold axis of symmetry. The contact area of the subunit 
interface (excluding residues with thermal parameters in excess of 80 Â2) is about the same 
in the mouse-muscle (5150 Â2), ligand-free E. coli [5270 Â\ (15)], A. thaliana [4830 Â2, 
(19)], and T. aestivum [5250 À2, (19)] enzymes. The subunit interface of the mouse-muscle 
dimer has fewer salt links than those of the E. coli or plant synthetases, a comparable number 
of hydrogen bonds, and more hydrophobic contacts. Lys174 makes a salt link with Asp263 
(donor-acceptor distance of 2.6 Â), which is an interaction conserved in all known synthetase 
structures (Fig. 2). Hydrogen bonds between subunits of the mouse-muscle synthetase 
replace other salt links of E. coli and plant synthetases. Hydrogen bonds number 28, 32, 24 
and 23 at the subunit interfaces of mouse-muscle, ligand-free E. coli, A. thaliana, and T. 
aestivum synthetases, respectively, using a distance cutoff of 3.3 À and a thermal parameter 
cutoff of 80 À2. Unique to the mouse-muscle synthetase are hydrogen bonds, AspI84-Asn392\ 
Serl87-Asn392#, Asp234-backbone carbonyl 389#, and Gln289-backbone carbonyl 355#. (The # 
symbol designates a residue from the subunit related by molecular symmetry). Hydrophobic 
contacts involve two clusters of non-polar side chains: Val236, Phe264#, Met352* and Val353#, 
and close to the molecular twofold axis. Met206, Phe207, Met206*, and Phe207* (Fig. 3). Plant 
synthetases have non-polar residues corresponding to Phe207, Val236, Phe264, and Val353, but 
Met206 and Met352 of the mouse-muscle enzyme correspond to polar residues in the plant 
synthetases. 
Catalytic function of adenylosuccinate synthetase from E. coli is sensitive to the 
integrity of the subunit interface. Mutations of Lys140 and Asp23', which correspond to Lys174 
and Asp263, respectively, of the mouse-muscle enzyme, inactivate the synthetase (42) or 
elevate the Km for IMP and GTP by 40- and 20-fold, respectively (38). At subunit 
concentrations below 10 jiM, and in the absence of active site ligands, the E. coli synthetase 
is largely monomelic (12) and presumably inactive, although the later has yet to be 
demonstrated. Synthetases from plants reportedly behave as monomers in gel filtration, but 
light scattering data are consistent with a dimer (19). The basic isozyme is reportedly a 
stable dimer (2,3,21,39). Conformational variations amongst synthetases in regions 
corresponding to residues 184—193, 204—213 and 385—395 of mouse-muscle enzyme 
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(Figs. 1&3) are at or close to the subunit interface of the dimer. Known crystal structures of 
synthetases, however, reveal no certain basis for differences in dimer stability, assuming such 
differences exist. 
The present structure provides no insight as to the role (if any) of the 30-amino acid 
extension to the N-terminus of the mouse-muscle enzyme (hereafter, the leader sequence). 
Leader sequences amongst members of the synthetase family are dissimilar. The fusion of 
lacZ to the N-terminus of the acidic human isozyme, however, results evidently in an inactive 
construct (43). As significant evidence stands against the direct participation of the leader 
sequence in catalysis (the £. coli synthetase, for instance, has no leader sequence), the fusion 
protein may be incapable of forming an active dimer. No evidence suggests, however, any 
change in catalytic properties or structure due to the presence of the N-terminal, His-tag. 
Active site— Loops 38—53, 120—131, 298—304 and 417—421 of the £. coli synthetase 
undergo significant conformational change in response to ligation of the active site (9,38). 
The corresponding loops in the mouse-muscle enzyme (residues 68—83, 151—165, 330— 
336 and 448—452, respectively) are probably sensitive to active site ligands as well. For the 
most part, residues in direct contact with active site ligands in the £. coli synthetase are 
identical to corresponding residues of the mouse-muscle synthetase. By analogy to the £. 
coli synthetase, loops 151—165, 330—336, and 448—452 are part of the IMP-, the L-
aspartate-, and the GTP-binding pockets, respectively, and specific residues of loop 68—83 
probably interact with IMP, GTP and Mg2>. 
As the aforementioned loops seem important to the function of all known synthetases, 
and yet have difference sequence numbers, we suggest a generalized nomenclature. 
Hereafter, we suggest the names Switch-loop, IMP-loop, Asp-loop and GTP-loop represent 
segments corresponding to residues 38—53, 120—131, 298—304 and 417—421, 
respectively of the £. coli synthetase (Fig. 1). 
As noted above, the IMP-loop of the mouse-muscle enzyme is disordered. In 
structures of the £. coli and plant synthetases without IMP the corresponding residues are 
also disordered. In the presence of IMP the conserved threonines at positions 162 and 163 of 
the mouse-muscle enzyme should hydrogen bond with the 5' phosphoryl group of IMP. The 
IMP-loop of the mouse-muscle enzyme has three more residues than those from £. coli and 
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plant synthetases (Fig. 2). Glu118 of E. coli synthetase, however, hydrogen bonds with the 
IMP-loop of the ligated enzyme (9). If Glu149 (the corresponding residue of the mouse-
muscle synthetase) plays a similar role, then the additional residues may influence the 
conformation of the mouse-muscle IMP-loop only as it emerges from helix H3. 
Conformational differences in this area of the IMP-loop, however, could still influence 
interactions between subunits of a synthetase dimer (Fig. 3). 
In contrast to the disordered Asp-loop of the E. coli synthetase, the corresponding 
loop of the mouse-muscle enzyme adopts a well-defined conformation, probably due to the 
stabilizing effect of lattice contacts (see above). The conformation of the Asp-loop in the 
basic isozyme is similar to that of the £. coli synthetase in its complex with hadacidin (an 
analog of L-aspartate) (9). On the basis of model building and energy minimization, the Asp-
loop of the mouse-muscle synthetase will retain its observed conformation, but move 5 Â 
toward the active site, in order to hydrogen bond with hadacidin. 
Superposition of the mouse-muscle and £. coli synthetases reveals a 1.6 Â root-mean-
squared difference between their respective GTP-loops. The observed difference may be 
related to a much larger conformational difference in Switch-loop, described below. 
Residues of the GTP-loop define in part the binding pocket for the base of the guanine 
nucleotide. In the £. coli synthetase, Ser414, the side-chain of which hydrogen bonds with the 
6-0 atom of the guanine nucleotide, and Pro4'7, which stacks against the base of the guanine 
nucleotide, are Gly420 and Lys423, respectively, in the mouse-muscle isozyme. Neither 
changes in residue type nor conformation here, however, greatly influence the Km for GTP 
(see above). In the plant enzymes Ser4'4 is also replaced by glycine. Evidently, the 
backbone amide of the glycine recognizes the 0-6 atom of the guanine nucleotide as well as 
the OG atom of Ser4'4. 
The Switch-loop of the £. coli synthetase adopts a ligand-free conformation or a 
ligated conformation, both of which differ significantly from that of the mouse-muscle 
synthetase (Fig. 1). The root-mean-squared difference between corresponding a-carbons of 
the mouse-muscle loop relative to the ligand-free and ligated £. coli loops is 3.0 and 2.7 Â, 
respectively. Hydrogen bonds involving Asn"6, Lys"9, and Gly120 with Asp81, Glu79, and 
Tyr80, respectively, stabilize the observed conformation of mouse-muscle Switch-loop. The 
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above residues, with the exception of Gly120, are different in £. coli and plant synthetases 
(Fig. 2). The ligand-free position of the corresponding loop in plant synthetases is unknown. 
Variations in the sequence of the plant synthetases relative to £. coli and mouse-muscle 
synthetases may give rise to yet another loop conformation in the absence of ligands. 
Regardless of the different ligand-free conformations for the above loop, the 
hydrogen bond between His71 and Asp51 (His41 and Asp21, respectively, in the £. coli 
synthetase) is present in each of the ligand-free synthetases, for which crystal structures are 
available. Furthermore, His41 of the £. coli synthetase is an essential catalytic residue (9,36), 
and Asp2' represents one-half of an important switching mechanism, which defines the 
ligated and ligand-free conformations of the £. coli synthetase (7,9,38). In the proposed 
switching mechanism (7), hydrogen bond formation between Asn38 and the 5'-phosphoryl 
group of IMP leverages the Switch-loop into its ligated conformation, which is stabilized 
further by the salt link between Asp2' and Arg4'9 (of the GTP-loop). As these residues are 
invariant over the known synthetase family, the histidine-aspartate and arginine-aspartate 
links, defined above, are probably hallmarks of the ligand-free and ligated conformations, 
respectively, of all adenylosuccinate synthetases. 
Conformational differences in the aforementioned loops are not entirely surprising, as 
these structures are flexible. The gain or loss of a single hydrogen bond can result in a 
significant conformational difference. Residues 35—38 of the £. coli synthetase, however, 
are well ordered with low thermal parameters. Hence, the significant difference in 
conformation for residues 65—68 of the mouse-muscle enzyme relative to residues 35—38 
of the £. coli enzyme is unanticipated (Fig. 4). In fact, not only is Asn68 of the mouse-muscle 
synthetase removed from the 5'-phosphoryl pocket of IMP, segment 65—68 sterically 
excludes IMP from binding (Fig. 4). Furthermore, a hydrogen bond between Asn265 and 
backbone amide 67 may stabilize the observed conformation of residues 65—68. Asn256 may 
itself be an important catalytic residue. Gin224 of the £. coli synthetase, which corresponds to 
Asn256 of the mouse-muscle enzyme, hydrogen bonds with the atoms N-7 and 0-6 of IMP, 
and putatively stabilizes the 6-oxyanion form of IMP (9,37). Finally, residues 65—68 have 
elevated thermal parameters, which suggest conformational mobility and the possibility of a 
ligand-induced conformational change. The conformation of this loop has been verified by 
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the collection of a data set from a second crystal, by the use of omit electron density maps, 
and by the refinement of an £. coli-Wkt model, the later resulting in an inferior fit to the 
electron density. The altered conformation of residues 65—68 may be a distinct feature of 
the ligand-free, basic isozyme, and may go hand-in-hand with the observed conformational 
differences in the Switch-loop. 
Any functional significance attached to the altered conformation of segment 65—68 
is merely speculative, but the muscle isozyme is inhibited at least 10-fold more potently by 
fructose 1,6-bisphosphate than the £. coli synthetase (Gorrell, A., Hou, Z., Honzatko, R. B. 
and Fromm, H. J., unpublished). Others have suggested a connection between glycolysis and 
the purine nucleotide cycle on the basis of the in vitro inhibition of the muscle isozyme by 
fructose 1,6-bisphosphate (2,5), but whether the in vivo concentrations of fructose 1,6-
bisphosphate in muscle ever rise to levels, which could cause appreciable inhibition of the 
synthetase, is unknown. Spector and Miller (40) report allopurinol ribonucleotide as a weak 
inhibitor of the synthetase from rabbit muscle, yet this IMP-analog is a substrate for the 
synthetase from the protozoan Leishmania donovanii (44). Variations in substrate specificity 
between muscle and protozoan synthetases may arise from conformational differences 
involving residues 65—68. Atom N-7 of IMP may need to hydrogen bond with Asn256 of the 
mouse-muscle enzyme in order to trigger a conformational change in residues 65—68. If so, 
atom N-7 of IMP would compete with backbone amide 66 for the side chain of Asn256 (Fig. 
4). The absence of a proton acceptor at position-7 of allopurinol ribonucleotide would give 
backbone amide 66 a clear advantage in stabilizing a conformation, which is antagonistic 
toward the IMP-analog. The existence of an active-site conformation, which excludes IMP 
also allows for alternative mechanisms of regulation. Conceivably, an inhibitor need not 
look like IMP or bind to the active site as does IMP, in order to inhibit the mouse-muscle 
enzyme. Any ligand that stabilizes the IMP-antagonistic conformation, observed here, would 
be an inhibitor of the synthetase. The muscle isozyme, then, may be sensitive to more than 
just feedback inhibition by AMP. Evidence indicates, for instance, an association of the 
muscle synthetase with F-actin (45,46). Hence, interactions between the muscle isozyme and 
other muscle proteins could influence, or even determine, the level of synthetase catalysis in 
vivo. 
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Table I. Statistics of data collection and refinement. 
Data reduction: 
Space group 
Unit cell parameters (Â) 
Resolution limits (Â) 
No. of reflections 
No. of unique reflections 
Completeness of data (%) 
Overall 
Last shell (2.59-2.5 Â) 
Ra merge 
Overall 
Last shell (2.59-2.5 Â) 
Refinement: 
No. of reflections" 
No. of atoms 
No. of solvent sites 
R7Rfreed 
Mean B for protein (Â2) 
Main-chain 
Side-chain 
Root-mean-squared deviations 
Bond lengths (Â) 
Bond angles (degrees) 
Dihedral angles (degrees) 
Improper dihedral angles (degrees) 
P4,2,2 
a=6=69.93. c= 198.49 
39.6-2.5 
132.963 
16.066 
90 
60 
0.063 
0.224 
16060 
3358 
96 
0.207/0.272 
37 
39 
0.006 
1.3 
23.5 
0.78 
aRmcrgc = IjI.|I,|-<I]>|/S,Sj Ijj. where t runs over multiple observations of the same 
intensity and j runs over crystallographically unique intensities. 
"All unique data in the resolution range 39.6-2.5 A. 
'R-factor = IIIW-IFcdcll/ZIW, |Fob,|>0. 
dR-factor based upon 10% of the data randomly culled and not used in the refinement. 
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Fif. 1. Seperpoeitioe of Imowa stractara of adeeykwecclaate syathctaacs la stereo. (Top) Stereoview of 
the Ca-tiace for mouse-muscle adenylosuccinate synthetase (yellow), including segments of ligand-free E. coli 
[(15), blue], ligated E. coli [(9), red], and GDP-ligated A. thaliana [(19), green] synthetases (top). Pairwise 
superpositions of ligand-free E. coli, ligated E. coli and GDP-ligated A. thaliana synthetases against the mouse-
muscle synthetase give root-mean-squared differences in superimposed C, carbons of 1.8, 1.6 and 1.0 À, 
respectively. The pairwise root-mean-squared difference is more than 2 A for at least one of the illustrated 
segments. Stereoview of the Switch-loop (bottom) shows its ligand-free (blue) and ligated (red) positions in the 
£. coli synthetase relative to its position in the mouse-muscle synthetase (yellow). Green dashes represent 
donor-acceptor interactions stabilizing the position of the loop in the mouse-muscle synthetase. This figure was 
drawn by MOLSCRIPT (47). 
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Fig. 2. Alignment of amino-acid sequences of synthetases on the basis of known 
structures. Regions of secondary structure for the mouse-muscle enzyme are directly 
beneath its sequence. Cylinders represent a- and 3 ^ -helices (the latter labeled with the 
prime symbol) and arrows represent (3-strands. Letters in bold typeface are identical in the 
alignment of all four sequences. Residues marked with an asterisk bind directly to an active 
site ligand in at least one of the synthetase structures. Residues boxed by thin lines are part 
of the subunit interface of the synthetase dimers. 
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Fig. 3. Subunit interface of mouse-muscle adenylosuccinate synthetase. Overview of the subunits in the 
dimer as viewed down its molecular twofold axis (top). A more detailed presentation of side-chain interactions 
(bottom). The viewing orientation is the same for top and bottom panels. This figure was drawn by 
MOLSCRBT (47). 
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Fig. 4. Stereoview of segment 65—68 of the mouse-muscle synthetase. Residues 65—68 
and associated omit electron density contoured at lo with a cutoff radius of 1 Â {top). 
Conformational differences between residues 65—68 of the mouse-muscle synthetase (bold 
lines) and corresponding residues of the ligand-free {middle) and ligated {bottom) E. coli 
enzyme. Dashed lines represent donor-acceptor interactions. 
37 
CHAPTER 3. IMP, GTP AND 6-PHOSPHORYL-IMP COMPLEXES OF 
RECOMBINANT MOUSE-MUSCLE ADENYLOSUCCINATE 
SYNTHETASE ^ 
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Abstract 
Prokaryotes have a single form of adenylosuccinate synthetase that controls the 
committed step of AMP biosynthesis, but vertebrates have two isozymes of the synthetase. 
The basic isozyme, which predominates in muscle, participates in the purine nucleotide 
cycle, has an active site conformation different from that of the Escherichia coli enzyme, and 
exhibits significant differences in ligand recognition. Crystalline complexes presented here 
of the recombinant basic isozyme from mouse show the following: GTP alone binds to the 
active site without inducing a conformational change. IMP in combination with an acetate 
anion induces major conformational changes, and organizes the active site for catalysis. 
IMP, in the absence of GTP, binds to the GTP pocket of the synthetase. The combination of 
GTP and IMP results in the formation of a stable complex of 6-phosphoryl-IMP and GDP, in 
the presence or absence of hadacidin. The response of the basic isozyme to GTP alone 
differs from that of synthetases from plants, and yet the conformation of the mouse basic and 
E. coli synthetases in their complexes with GDP, 6-phosphoryl-IMP and hadacidin are nearly 
identical. Hence, reported differences in ligand recognition amongst synthetases probably 
arise from conformational variations observed in partially ligated enzymes. 
Introduction 
Adenylosuccinate synthetase [IMP:l-aspartate ligase (GDP-forming), EC 6.3.4.4] 
catalyzes the committed step in the de novo biosynthesis of AMP. Due to its critical role in 
purine biosynthesis, the synthetase is a target for antibiotics, herbicides and antitumor drugs 
(1-4). In contrast to other organisms that have only one adenylosuccinate synthetase, 
vertebrates possess two isozymes of the synthetase that differ in their isoelectric points, 
kinetic properties, tissue distribution, and in vivo regulation (5-6). The basic (often called the 
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muscle synthetase or AdSSl) and the acidic (often called the liver synthetase or AdSS2) 
isozymes may participate exclusively in the purine nucleotide cycle and de novo biosynthesis 
of AMP, respectively (7-9). But hard evidence in support of distinct physiological roles for 
the two vertebrate isozymes remains elusive (10). Nonetheless, high concentrations of IMP 
found in exhaustively exercised muscle inhibit only the basic isozyme (11-13). 
The kinetic mechanism for the synthetase from Escherichia coli is rapid equilibrium 
random (14). The reaction begins with the transfer of the y-phosphoryl group of GTP to the 
6-keto group of IMP to form 6-phosphoryl-IMP (6PIMP), followed by the displacement of P. 
from the intermediate by l-aspartate to form adenylosuccinate (15-19). Crystal structures of 
recombinant synthetases from £. coli (17-26), from plants, Arabidopsis thaliana and Triticum 
aestivum (27), and from mouse muscle are available (28), but only in the case of the 
synthetase from E. coli are structures available for ligand-free (20,22), partially-ligated 
(21,26) and fully-ligated enzymes (17-19,23-24). Indeed, crystalline complexes of the £. coli 
synthetase have revealed 6-thiophosphoryl-IMP (18) and 6PIMP (19) at the active site, as 
well as determinants of ligand-induced conformational change (26). Evidently, IMP alone 
can induce long-range ordering of the active site of the £. coli synthetase, presumably 
through the formation of a hydrogen bond between its 5 -phosphoryl group and Asn38 (26). 
The most significant of the conformational changes is a 9 Â movement of loop 40-53 (now 
called the Switch loop). In contrast, crystal structures of synthetases from plants reveal 
organized active sites in the presence of GDP alone (27), but the ligand-free conformations 
for these enzymes are not available. 
The pre-Switch loops of the £. coli synthetase and the mouse basic isozyme, segments 
that include the critical asparagine at the IMP pocket, have decidedly different conformations 
in their ligand-free states (28). The conformational difference may contribute to variations in 
ligand recognition within the synthetase family (5-6, 13, 29-31). To better understand 
determinants of substrate recognition, we examine here crystalline complexes of the mouse 
basic isozyme formed in the presence of GTP alone, IMP alone, GTP/IMP, and 
GTP/IMP/hadacidin. (Hadacidin, iV-formyl JV-hydroxyglycine, is a tight-binding, 
competitive inhibitor with respect to l-aspartate). In contrast to the plant synthetases, 
guanine nucleotides alone cannot organize the active site of the mouse basic isozyme. 
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Furthermore, consistent with reports of 6-phosphoryl-IMP at the active site of the E. coli 
synthetase, the mouse basic isozyme also stabilizes the intermediate in the presence and 
absence of hadacidin. In fact, structural complexes of the mouse basic isozyme and E. coli 
synthetase suggest that anions at the 5'-phosphoryl site of IMP and the ^-phosphoryl site of 
GTP synergistically trigger organization of the active site. Evidently, the mouse basic 
isozyme and the E. coli synthetase differ in their ligand-free conformations, but are nearly 
identical in their states of complete ligation. Finally, the complexes above provide a 
structural basis for IMP-inhibition of the mouse basic isozyme at high concentrations of IMP. 
Materials and Methods 
Materials— Hadacidin was a generous gift from F. Rudolph and B. Cooper (Department of 
Biochemistry and Cell Biology, Rice University, Houston, TX). All other reagents came 
from Sigma. 
Purification and Crystallization of the Recombinant Mouse Muscle Isozyme— The mouse 
basic isozyme was prepared as described previously (28) and was at least 95% pure on the 
basis of SDS-polyacrylamide gel electrophoresis (data not shown). Crystals were grown by 
the method of hanging drops and combined equal volumes (3 ^L) of protein and 
crystallization solutions. The protein solution (10 mg/mL enzyme in 50 mM Hepes, pH 7.5, 
50 mM NaCl, I mM dithiothreitol, and 0.5 mM EDTA) included IMP (10 mM in the IMP 
complex, 5 mM in the 6PIMP/GDP and 6PIMP/GDP/hadacidin complexes), GTP (5 mM), 
and/or hadacidin (2 mM). The crystallization buffer contained 200 mM magnesium acetate, 
100 mM Hepes, pH 7.0, and polyethylene glycol 8000 or 3350. Equal-dimensional prisms 
appeared for the GDP/GTP and 6PIMP/GDP/hadacidin complexes in 18% (w/v) and 13% 
(w/v) polyethylene glycol 8000, respectively. Plate-like crystals came from 18-19% (w/v) 
polyethylene glycol 3350 for IMP and 6PIMP/GDP complexes. Transfer of crystals to 
cryogenic solutions followed a published protocol (28). The final cryogenic solution 
contained 21% (v/v) glycerol and equal parts of the above protein (less the protein) and 
crystallization solutions. 
Data Collection— Data for the 6PIMP/GDP/hadacidin complex were collected at the 
Structural Biology Center (SBC), beam line 19-BM, Advanced Photon Source (APS), 
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Argonne National Laboratory, using the SBC-2 CCD detector. The wavelength of x-
radiation was 0.979 Â. Data reduction was done with Denzo/Scalepack package (32). Other 
data sets were collected on a Rigaku R-AXIS IV++ image-plate detector, using CuKa 
radiation from an Osmic confocal optics system, and CrystalClear data reduction. 
Model refinement— Initial phases for all complexes reported here came by molecular 
replacement, using the structure of the ligand-free mouse synthetase (accession label 1J4B) 
less waters of solvation. The GTP/GDP and 6PIMP/GDP/hadacidin complexes were 
isomorphous to crystals of the ligand-free enzyme. Solutions to the rotation and translation 
functions came from AmoRe (33) for the IMP and 6PIMP/GDP complexes. Models for 
ligands were fit to omit electron density maps. Manual adjustments in the model and 
refinement employed XTALVIEW (34) and CNS (35), respectively. Force constants and 
parameters of stereochemistry came from Engh and Huber (36) and those for hadacidin from 
Poland et al. (23). Refinement of the models followed the same protocols as described 
previously (28). Estimates of coordinate error used the method of Luzzati (37). 
Stereochemistry of the refined models was evaluated with PROCHECK (38). Superposition 
of structures was done with software from the CCP4 package (39). 
The y-phosphoryl group of GTP in the GTP/GDP complex initially exhibited high 
thermal parameters relative to those of its (3- and a-phosphoryl groups. An occupancy factor 
of 0.5 for atoms of the y phosphoryl group of GTP resulted in thermal parameters 
comparable to those of the (3- and a-phosphoryl groups, and nearby atoms of the protein. 
Results 
All ligand complexes crystallize from solutions containing 200 mM Mg(OAc)a and Hepes 
buffer, pH 7, and provide data to 2.1-2.2 À resolution. Crystals of the ligand-free basic 
isozyme, the GTP/GDP complex, and the 6PIMP/GDP/hadacidin complex are isomorphous 
(space group P4]2i2), having one subunit of a synthetase dimer in the asymmetric unit of the 
crystal. 6PIMP/GDP and IMP complexes are also isomorphous (space group C2), but have a 
complete dimer in the asymmetric unit of the crystal. Statistics of data collection and 
refinement are in Table I. The stereochemistry of the refined models, as defined by the 
program PROCHECK, exceeds that usually observed for protein structures of comparable 
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resolution. No residues lie in disallowed regions of the Ramachandran plot, and at least 88% 
of all residues for any given structure are in the most favored regions. The average 
uncertainty in coordinates is approximately 0.25 Â. Thermal parameters vary from 17-100, 
10-67, 18-78, and 17-81 Â2 for the GTP/GDP, IMP, 6PIMP/GDP, and 
6PIMP/GDP/hadacidin complexes, respectively. Regions of weak or absent electron density 
correspond to short segments of specific loops, described more completely below, and to 
residues preceding Ala28. The presence or absence of a poly-histidyl tag at the N-terminus 
has no effect on the formation of crystals, or on the structures of the resulting complexes 
(data not provided). 
Dynamic structural elements of adenylosuccinate synthetase, recognized from 
previous work, are the Switch, IMP, GTP, and Asp loops (Fig. I). Work here reveals two 
additional dynamic elements, the pre-Switch and the Val loops. The later name originates 
from the invariance of Val305 amongst sequences of the synthetase family. Mutations of 
Val273 in the E. coli enzyme (the residue corresponding to Val305 of the mouse basic isozyme) 
seriously impair the synthetase's ability to discriminate between l-aspartate and other 
physiologically relevant dicarboxylic acids (40). Removing the six dynamic loops from 
consideration, all structures of the mouse basic isozyme, including the ligand-free structure, 
superimpose with an overall root-mean-square deviation in Ca coordinates of less than 1.3 
Â. The structural elements named above, however, exhibit different conformational states 
(ligated, ligand-free, or disordered), which are the focus of this investigation and are 
summarized in Table II. The 6PIMP/GDP/hadacidin complex of the mouse basic isozyme 
defines the ligated conformation for each of the structural elements in Table II, whereas the 
ligand-free crystal structure reported by Iancu et al. (28) defines the "unligated" 
conformations. E. coli synthetase structures are available for the ligand-free, IMP, 
6PIMP/GDP and 6PIMP/GDP/hadacidin systems (19-20, 22, 26), but not for the GTP/GDP 
complex. What follows is a detailed account of the key structural features for each of the 
subunits in partially and completely ligated complexes of the mouse basic isozyme. 
GTP/GDP complex (accession label I LOO)— All active site loops in the GTP/GDP 
complex, with the exception of GTP loop, have conformations similar to those seen in the 
ligand-free basic isozyme (Table II). Strong electron density within the guanine nucleotide 
42 
pocket is consistent with mutually exclusive binding of GDP and GTP, each at 50% 
occupancy (Fig. 2). The base of GTP/GDP lies between the guanine recognition element 
(residues 362-365), which matches the consensus sequence (N)/TKXD common to G-
proteins (42), and the GTP loop (Fig. 1). The base of the guanine nucleotide makes several 
hydrogen bonds with the protein: Atom N-l and the 2-amino group hydrogen bond with 
Asp365, and atom 0-6 hydrogen bonds with backbone amides 363 and 447 (Fig. 2). The side 
chains of Lys363 and Lys448 pack against opposite faces of the base moiety. Only Lys363 
hydrogen bonds with the ribose moiety (with atom 04'), but as noted below, other 
interactions between protein and ribose are evident in the fully ligated system. The P-loop 
(residues 38-46) hydrogen bonds extensively with the phosphoryl moiety of GTP/GDP: 
Backbone amides 45 and 46 interact with the ^-phosphoryl group, and backbone amide 43 
and the side chains of Asp43 and Lys46 with the y-phosphoryl group. Spheres of electron 
density, modeled as four separate water molecules, extend from the phosphoryl moiety of 
GTP (Fig. 2). The assigned water molecules could represent sites of Mg2+ coordination 
and/or density from conformational disorder in the y-phosphoryl group of GTP. Unlike the 
fully ligated synthetase (see below), the GTP/GDP complex does not define a specific 
binding site for Mg2*. 
IMP complex (accession label 1IWE)—The asymmetric unit contains a dimer, the subunits 
of which differ in their ligation, lattice contacts and loop conformations. Chain A binds one 
molecule of IMP and two molecules of acetate, whereas chain B binds two molecules of IMP 
and one Mg2+ (Fig. 3). The Asp loop of each subunit makes different lattice contacts: In 
chain A, backbone carbonyl 333A hydrogen bonds with the side chain of Lys336A#, and the 
side chain of Trp329A hydrogen bonds with backbone carbonyl 334A* and stacks with the side 
chain of Trp329A*. (The # symbol designates a residue from a lattice contact). In chain B, 
backbone carbonyls 332B, 333B and 334B hydrogen bond with the side chains of Ser428B#, 
Arg43lB# and Asn435B#, respectively. The Asp loop of chain A packs against the active site 
(ligated conformation), whereas that of chain B stands-off from the active site by a rigid-
body motion of approximately 5 Â (ligand-free conformation, Fig. 4). The Val and pre-
Switch loops, also exhibit different conformations in chains A and B: The Val loop and Asn68 
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(of the pre-Switch loop) move approximately 2 and 1.5 Â, respectively, away from the active 
site in chain B relative to their positions in chain A (Fig. 4). 
In contrast, the Switch and IMP loops of chains A and B adopt the same 
conformation, that of the fully ligated active site of the basic isozyme. Relative to the ligand-
free structure, the Ccc atoms of the Switch loop have moved by as much as 5 Â. The IMP 
loop has no electron density associated with it in crystal structures of the ligand-free and 
GDP/GTP-ligated structures, but in the IMP complex it is in a well-defined conformation 
with distinct electron density. Residues 147-156 complete helix H3; positions 154-156, 
which are insertions with respect to sequences of the E. coli and plant synthetases, just 
extend helix H3 by an additional turn. The side chain of Glu149 (helix H3) hydrogen bonds 
with backbone amides 160, 161 and 162, stabilizing an ordered conformation for the IMP 
loop. 
The side chains of Asn68, Thr163, Thr271, and Arg177 (from the symmetry-related 
subunit of the dimer) and backbone amide 163 hydrogen bond with the 5'-phosphoryl group 
of IMP in both chains A and B, but beyond this the recognition of IMP in each subunit 
differs substantially (Figs. 3&4). In chains A and B, the ribosyl moiety of IMP is CT-endo 
and CT-endo, respectively, and the torsion angles of the glycosidic bonds (%) are 23° and 
80°. The 2'-hydroxyI group of IMP at chain A hydrogen bonds with the side chain of 
Arg335A (Asp loop) and backbone carbonyl 305A (Val loop), and its 3-hydroxyI group 
interacts with backbone carbonyls 160A and 307A, and with the side chain of Arg304A by 
way of bridging water molecules. In contrast, the 2'- and 3'-hydroxy 1 groups of IMP at chain 
B hydrogen bond only with backbone carbonyl 160B, the latter directly and the former 
through a bridging water molecule. The N-7 atom of IMP at chain A hydrogen bonds with 
the side chain of Asn256A, whereas the side chain of Asn2568 is more that 7 Â away from the 
N-7 atom of IMP. In spite of this difference, Asp43 retains its hydrogen bond with the N-l 
atom of IMP in both subunits. In essence, IMP is bound to chain A as in the fully-ligated 
complex of the basic isozyme, whereas IMP binds to chain B in a mode not observed in any 
previous structure of the synthetase. 
Significant differences in the ligation of chains A and B extend beyond the IMP pocket to 
the l-aspartate and GTP pockets. A molecule of acetate hydrogen bonds with the side chains 
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of Thr333A and Arg335A, and backbone amides 332A and 333A (essentially the putative (i-
carboxylate site for L-aspartate). The corresponding site at chain B is free of electron 
density, and the side chain of Arg3358 extends far into the solvent. A second molecule of 
acetate occupies the ^-phosphoryl site of the GTP pocket in chain A, hydrogen bonding to 
backbone amides 45A and 46A, the side chain of Lys401* and either a water molecule or the 
side chain of His71A. Interactions of the acetate anion at the GTP pocket are virtually 
identical to those of ^-phosphoryl group of GDP in the fully ligated complex (see below). In 
the GTP pocket of chain B a second molecule of IMP binds along with Mg2* (Fig. 3). The 
base and ribose of IMP here have interactions similar to those of GDP in its fully ligated 
complex: the side chains of Asp3658 and Lys3638 hydrogen bond with the N-l and 0-4' atoms, 
respectively, backbone amides 363B and 447B with the 0-6 atom, and Lys4488 with both the 
2'-and 3-hydroxyI groups. Backbone amides 45B, 46B, 47B and 72B hydrogen bond with 
the 5-phosphoryl group of IMP; that group coincides with the a-phosphoryl group of GDP 
in the GTP/GDP complex, and lies between the a- and ^-phosphoryl sites of GDP in the 
fully ligated complex. Mg2+ coordinates the 5'-phosphoryl group, backbone carbonyl 70B, 
and four water molecules, which in turn hydrogen bond with the side chains of Asp438 and 
Thr728 and backbone carbonyl 69B. The Mg2+ site is 2 Â removed from its position in the 
fully ligated complex. Conformational changes in the main chain of pre-Switch loop 
residues 67-70 (see Figs. 3&4) may be responsible in part for the 1.5 Â shift in the side chain 
of Asn688, and the nonproductive binding of IMP to the IMP pocket of chain B. 
6PIMP/GDP complex (accession label 1LNY)— Mg2+, 6PIMP and GDP are at each of the 
symmetry-unique subunits (Fig. 5). The lattice contacts involving chain A of the Asp loop, 
save the side chain stacking between Trp329A and Trp329A#, are not evident. Perhaps as a 
consequence, weak electron density covers the Asp loop of chain A from Gly330A to Gly334A, 
and electron density at the acetate binding site, clearly observed at chain A of the IMP 
complex, is diffuse in the 6PIMP/GDP complex. Nonetheless, Arg335A remains in distinct 
electron density and hydrogen bonds with the 2'-hydroxyl group of IMP. In contrast, lattice 
contacts and electron density associated with the Asp loop of chain B are indistinguishable 
from those of chain B in the IMP complex (see above). 
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Interactions involving 6PIMP, GDP and Mg2* are for the most part the same at each 
subunit (Fig. 5). The IMP moiety of 6PIMP has the interactions of the IMP molecule at 
chain A of the IMP complex (see above). The 6-phosphoryl moiety of 6PIMP hydrogen 
bonds with backbone amides 43, 46, 70 and 256, and with the side chains of Lys46 and His71 
(Fig. 5). In addition, one oxygen atom each from the 6-phosphoryl group of 6PIMP, the side 
chain of Asp43, the a- and ^-phosphoryl groups of GDP, and the backbone carbonyl 70, 
coordinate the active site Mg2+ (a total of five oxygen atoms). The Mg2* at chain B has its 
sixth coordination site occupied by a water molecule, whereas the sixth coordination site of 
Mg2+ at chain A is open. Backbone carbonyls 305 in the Val loop of chains A and B have 
opposite relative orientations: In chain A backbone carbonyl 305 hydrogen bonds with the 
2'-hydroxyl group of 6P1MP, whereas backbone amide 306 of chain B makes the hydrogen 
bond with the 02' atom. 
Interactions involving the base and ribose of GDP in the 6PIMP/GDP and GTP/GDP 
complexes differ only by the presence of hydrogen bonds between Lys448 and the 02' and 
03' atoms of GDP in the 6PIMP/GDP complex. The binding site for the ^-phosphoryl group 
of guanine nucleotides is comparable in the GTP/GDP and 6PIMP/GDP complexes, but a 
rotation of 120° about the C4'-C5' bond of GDP places the a-phosphoryl group at a new 
location. The a-phosphoryl group of GDP interacts with the backbone amide 45 and 72, and 
the side chain of Thr72. The p-phosphoryl group hydrogen bonds with backbone amides 44, 
45, 46, and 47. and with the side chains of Lys46 and His71. Relative to the GDP/GTP 
complex, the most significant difference in the binding of GDP in the 6PIMP/GDP complex 
is the additional hydrogen bonds contributed by residues of the Switch-loop (His71 and 
Thr72). 
6PIMP/GDP/hadacidin-complex (accession label 1LON)— 6PIMP, GDP, hadacidin and 
Mg2+ are present at a completely organized active site (Fig. 6). The asymmetric unit of this 
crystal form has but one protein subunit. The Asp loop is ordered; side chains of Thr333 and 
Arg335, and backbone amides 332 and 333 hydrogen bond with the carboxyl group of 
hadacidin OV-formyl /V-hydroxyglycine). The N-formyl group of hadacidin coordinates the 
active site Mg2+, displacing the water molecule observed in the 6PIMP/GDP complex, and 
the N-hydroxyl group hydrogen bonds with the side chains of Asp43 and Arg337. The latter 
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side chain also interacts with a-phosphoryl group of GDP but otherwise protein-ligand 
interactions involving 6PIMP and GDP are identical to those of the 6PIMP/GDP complex. 
The side chain of Thr332 hydrogen bonds with backbone carbonyl 68 and/or the side chain of 
His83. 
Discussion 
Structures reported here reaffirm, at a higher resolution, the assignment of 6PIMP to 
electron density at the active site of the fully ligated synthetase from £. coli. The mouse 
muscle and E. coli enzymes have GDP, 6PIMP, hadacidin and a single, octahedrally 
coordinated Mg2+ at the active site. Furthermore, the formation of the 6-phosphoryl 
intermediate does not depend on the presence of L-aspartate or a tight-binding analogue of L-
aspartate, such as hadacidin. Indeed, the formation of 6PIMP is insensitive to the 
conformational state of the Asp loop; 6PIMP is present at chain B of the 6PIMP/GDP 
complex, even though the Asp loop is in its ligand-free conformation (Table II). A total of 
39 hydrogen and coordinate bonds between ligands and protein are present in both fully 
ligated £. coli and mouse muscle synthetases. The structural similarity in ligated active sites 
of the mouse and £. coli synthetases is consistent with similar Km values reported for each 
system (28,40,43). 
Sequence comparisons infer a common mechanism of catalysis for all members of the 
synthetase family. The first reaction of the proposed two-step mechanism (5,6,15) requires 
only IMP, GTP and Mg2+ (16). Asp43 (Asp13 in the £. coli synthetase) putatively abstracts 
the proton from the N-l atom of IMP, forming the 6-oxyanion of IMP. Mg2+ and His71 
(His41 in the £. coli synthetase) stabilize charge development on the P-phosphoryl group of 
the guanine nucleotide, the former by coordinating to the bridging oxygen atom between the 
(3- and y-phosphoryl groups and the latter by hydrogen bonding with a terminal oxygen of the 
P-phosphoryl group of GTP. The three terminal oxygen atoms of the y-phosphoryl group of 
GTP participate in numerous hydrogen bonds, which are essentially identical to those of the 
6-phosphoryl group of 6PIMP. The reaction coordinate for the phosphoryl-transfer reaction 
is simply the movement of the Py atom through the plane defined by its three terminal 
oxygen atoms. After formation of 6PIMP, Asp43 (now protonated) moves into the 
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coordination sphere of the catalytic Mg2+ (17-19). As a consequence, Asp43 becomes a 
catalytic acid and re-protonates the N-l atom of 6PIMP, thereby generating the C-6 cation of 
the intermediate (18,19). 6PIMP, in equilibrium with its C-6 cationic form, persists until L-
aspartate binds to the active site, and initiates the second step of the reaction. A detailed 
mechanism for the second step of the reaction mechanism is provided elsewhere (44). 
Although largely the same, some differences are evident between the mouse muscle 
and £. coli synthetases: Lys448 in the mouse enzyme hydrogen bonds with the 0-2' and 0-3' 
atoms of GDP, but in the £. coli and plant systems the corresponding residue is a proline. 
Backbone amide 447 of the mouse enzyme hydrogen bonds with the 0-6 atom of GDP, but 
the side chain of Ser414 assumes that role in the £. coli synthetase. In the fully ligated 
complex of the £. coli synthetase. Gin224 maintains donor-acceptor distances of 2.7 and 2.9 Â 
with the N-7 and 0-6 atoms of IMP, respectively, whereas Asn256 of the mouse isozyme 
maintains corresponding distances of 2.8 and 3.2 À in the 6PIMP/GDP/hadacidin complex 
and 2.7 and 4.0 A in chain A of the IMP complex. Although Gin224 optimizes hydrogen 
bonds with the base of IMP in the £. coli complex, it does so at an increased entropie 
penalty. The side chains of Asn256 and Gin224 lose two and three rotational degrees of 
freedom, respectively, in their fully ligated complexes. Hence, the relatively weak hydrogen 
bonds of Asn256 may contribute as much to the free energy of complex formation as the 
strong hydrogen bonds of Gin224. Gin224 is an important catalytic side chain in the £. coli 
synthetase, presumably because of its potential to stabilize the 6-oxyanion of IMP prior to its 
nucleophilic attack on the y-phosphoryl group of GTP (15,18,43). Mutations of position 224 
reduce catalytic rates by 10- to 10,000-fold, with only modest effects on the Km of IMP (43). 
Chain A of the IMP complex of the mouse isozyme is virtually identical to the IMP 
complex of the £. coli synthetase (26). The active sites of both systems are in their fully 
ligated conformations, save for the Asp loop of the £. coli complex, which has high thermal 
parameters. In chain A of the mouse complex, acetate molecules bind to the Asp loop and to 
the P-phosphoryl pocket of GDP. One water molecule occupies each of the corresponding 
positions in the £. coli complex, but the thermal parameters for these water molecules are 
less than half of those of nearby atoms of the protein. Hence, electron density in the £. coli 
complex may represent bound acetate molecules as well. The higher resolution data of the 
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mouse relative to the E. coli complex (2.1 vs. 2.8 Â) clearly favors ordered acetate molecules 
as opposed to a set of mutually exclusive water molecules, whose fractional occupancies sum 
to unity. In light of these new data, the fully ligated conformation of IMP complexes may 
stem from binding synergism between IMP and acetate molecules. The movement of the 
Switch loop from its ligand-free to ligated conformation then may require interactions at the 
5*-phosphoryl site of IMP and the P-phosphoryl site of GTP. 
Significant differences in the binding of IMP to chain B of the mouse isozyme may 
be due in part to lattice contacts, which stabilize the Asp loop in a conformation "outwardly" 
displaced from the active site. (This conformation of the Asp loop is called its ligand-free or 
"unligated" conformation in Table II). The Val loop, itself outwardly displaced, no longer 
recognizes the ribosyl moiety of IMP by way of a hydrogen bond with backbone carbonyl 
305. The "outward" tilt of the base moiety of IMP is possible sterically because of the 
outward displacement of the Val and Asp loops. The conformational change in the side 
chain of Asn68 (an "outward shift" as well) is consistent with the general trend, but perhaps 
of greater significance are the conformational changes in the backbone of residues 68 and 69 
of the pre-Switch loop. Backbone carbonyl 69 in particular sterically forces the base of IMP 
from its pocket. This new backbone conformation for residues 68 and 69 may stem from the 
coordination of Mg2+ (associated with the IMP molecule bound to the GTP pocket) to 
backbone carbonyl 70. 
The ligation of the GTP pocket of chain B by IMP suggests a mechanism by which 
IMP can inhibit the synthetase. Indeed GTP-antagonized inhibition of the mouse basic 
isozyme at high concentrations of IMP was reported in early work (12), but under conditions 
of saturating GTP and L-aspartate, no substrate inhibition was evident up to a concentration 
of 0.5 mM IMP (28). IMP concentrations higher than 1 mM, however, do result in inhibition 
of catalysis (Tudor Borza and Herbert Fromm, unpublished data). As IMP concentrations in 
exhaustively exercised muscle rise to 3.6 mM (12), the binding of IMP to the GTP pocket of 
the synthetase may occur in vivo under these conditions. 
Superposition of the GDP/GTP complex of the mouse basic isozyme onto guanine 
nucleotide complexes of the E. coli synthetase (accession labels 1HOP, 1HON, 1HOO), 
derived from soaks of ligand-free crystals, reveals near exact agreement in the position of the 
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phosphoryl, ribose, and base moieties of the nucleotides. Electron density for an alternative 
position of the P-phosphoryl group of the guanine nucleotide in coordinate file I HON, 
however, maps onto a water molecule of the GDP/GTP complex reported here. The mouse 
and E. coli guanine nucleotide complexes have their P-phosphoryl pockets occupied, but no 
ligand at their IMP, 5'-phosphoryl sites. The Switch loop remains in its ligand-free 
conformation, consistent with the hypothesis stated above, that anion binding to the P-
phosphoryl site of GTP and the 5'-phosphoryl site of IMP are minimal requirements for 
driving the Switch loop into its ligated conformation. 
Under conditions of complete ligation, the E. coli and mouse synthetases (and 
presumably all other synthetases as well) are virtually identical. Yet in contrast, significant 
conformational differences are evident amongst partially ligated and ligand-free states of 
synthetases. In GDP complexes of plant synthetases, for instance, the Switch loop is in its 
fully ligated conformation (27). Evidently, the plant synthetases and the basic isozyme from 
mouse may have different response mechanisms to GDP/GTP. As suggested by Prade et al. 
(27), Tyr61 of the plant systems may stabilize the ligated conformation of the Switch loop by 
its hydrogen bond with the ribosyl moiety of GDP, an interaction not possible for synthetases 
from E. coli or mouse. In addition, the binding of IMP to the GTP pocket has not been 
observed in the IMP complex of the E. coli enzyme, suggesting again another difference 
revealed under conditions of partial ligation. Finally, the ligand-free synthetases from mouse 
muscle and E. coli differ in the conformation of their pre-Switch loops (28). Observed 
variations in binding affinities for fructose-1,6-bisphosphate, IMP, IMP analogues, and l-
aspartate (5,6) probably arise then from structural variations in the ligand-free and partially-
ligated states of synthetases. 
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Table I. Statistics of data collection and refinement. 
GTP/GDP 
complex 
IMP 
complex 
6PIMP/GDP 
complex 
6PIMP/GDP 
/hadacidin 
complex 
Data reduction 
Space group P432[2 C2 C2 P432t2 
Unit cell parameters 
a  ( À )  70.06 129.98 128.50 70.78 
b ( k )  70.06 69.99 70.12 70.78 
c(A) 198.09 105.33 105.13 195.63 
pn - 95.28 90.46 -
Resolution limits (Â) 65.9-2.2 40.8-2.1 40.5-2.2 50.0-2.1 
No. of reflections 126,081 183,394 175,127 266,913 
No. of unique reflections 25,715 52,718 48,646 32,291 
Completeness of data (%) 
Overall 89.5 95 92.3 98.5 
Last shell3 98.5 68 86.5 99.5 
r b immerge 
Overall 0.081 0.086 0.047 0.048 
Last shell3 0.312 0.278 0.222 0.178 
Refinement 
No. of reflections6 25,407 48,351 43,159 29,386 
No. of atoms 3352 6701 6701 3353 
No. of solvent sites 100 438 317 186 
"Resolution range is approximately 2.3-2.2 Â for the GDP/GTP and 6PIMP/GDP complexes, 
and 2.2-2.1 À for the IMP and 6PIMP/GDP/hadacidin complexes. 
bRmerge = ZjZi|Iij-<Ij>|/XiZj Iij, where i runs over multiple observations of the same intensity 
and j runs over crystallographically unique intensities. 
CA11 unique data in the resolution range 10-2.2 À for the GTP/GDP complex, 5-2.1 À for the 
IMP complex, 5-2.2 À for 6PIMP/GDP complex, and 10-2.1 k for 6PIMP/GDP/hadacidin 
complex. 
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Table I. (continued) 
GTP/GDP 
complex 
IMP 
complex 
6PIMP/GDP 
complex 
6PIMP/GDP 
/hadacidin 
complex 
Rd/RfreeC 0.244/0.276 0.202/0.253 0.207/0.259 0.224/0.271 
Mean B for protein (Â2) 
Main chain 44 24 36 39 
Side chain 46 26 38 43 
Root mean square 
deviations 
Bond lengths (Â) 0.006 0.006 0.006 0.007 
Bond angles (°) 1.2 1.3 1.2 1.3 
Dihedral angles (°) 23.0 23.1 23.1 23.0 
Improper dihedral 
angles (°) 0.82 0.78 0.86 0.87 
dR-factor = Z||Fobs|-|Fcaic||/X|Fobs|. |FObs|>0. 
eR-factor based upon 10% of the data randomly culled and not used in the refinement. 
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Table H. Conformational status of six dynamic loops of the recombinant mouse basic 
isozyme. The symbols U and L represent loop conformations observed in the ligand-free and 
fully ligated synthetases, respectively. The symbol D represents a state of disorder for which 
no assignment of conformation is possible due to weak or absent electron density. Subtle 
variations in the U and L conformations are explained by footnotes to this table. Loops are 
defined in Fig. I. 
Name of Complex Name of Loop 
Pre-Switch Switch IMP Val Asp GTP 
Ligand-free1 U U D U U U 
GTP1 u U D U u L 
IMP-Chain Ab L L L L L L 
IMP-Chain Bb Lc L L U U L 
6PIMP/GDP-ChainAb L L L L L L 
6PIMP/GDP-ChainBb L L L L" U L 
6PIMP/GDP/hadacidin L L L L L L 
"Belongs to the space group P4a2i2 with a single subunit in the asymmetric unit. 
^Belongs to the space group C2 with a two subunits in the asymmetric unit. 
cThe backbone conformation of residues 68 and 69 differ from the ligated conformer (see 
Fig. 4), but residues 65-67 are in the ligated conformation. This conformational variation is 
observed in AMP-ligated active sites of the mouse basic isozyme5. 
^The peptide linkage between residues 305 and 306 reorients by a rotation of approximately 
180° relative to the ligated conformation. 
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fore-Switch | loop .prc-Swuch | l'*>P 
Switch 
loop 
Switch 
loop 
Fig. 1. Stereo view of a single subunit of the mouse basic isozyme in its fully ligated 
conformation. Bold lines delineate the pre-Switch (residues 65-69), Switch (residues 70-
83), IMP (residues 152-165), Val (residues 304-310), Asp (residues 330-336) and GTP 
(residues 448-452) loops. Ligands (labeled GDP, 6PIMP, and HAD for hadacidin) are in 
wire-frame representation. A filled circle (labeled Mg) represents the site of Mg2+ binding. 
This figure was drawn with MOLSCRIPT (41). 
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K363 
I War 530 
Fig. 2. Stereo view of GTP bound to the active site. Electron density is from an omit map 
(coefficients of 2F0bs-Fcaic, otcaic phases) contoured at 3a using a cutoff radius of 1 Â. Dashed 
lines represent donor-acceptor interactions. 
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H71A H71A 
D43A 
N68A N68A -_LT333A -AT333A CT 
T163A T163A. 
V305A 
R335A 
T271A 
R177B R177B 
K448S 
K363B 
..«Wat 936 
'Wat 904 
T163B 
R177A R177A 
[11600 II60B 
Fig. 3. Stereoview of different modes of IMP ligation. Interactions at the two subunits of the asymmetric 
unit of this crystal form differ One IMP molecule and two acetate anions (labeled ACT) bind at chain A (top) 
and two IMP molecules and Mg2* bind at chain B (bottom). Electron density is from an omit map (coefficients 
of IFoia-Fcuc, Occ phases) contoured at 3<y using a cutoff radius of 1 Â. Dashed lines represent donor-acceptor 
interactions and coordinate bonds to the Mg2*. 
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H71 
N6' 170: V331 
332 ACT. %69 
G330 
ACT/ 
IN68 G334 T333 
V305 R335 
'IMP 
R304' 
,1307 
•G308 
IMP 
H71 
N67 G7( V331 
T332 ACT 
.69 
G330 
ACT/ 
1N68 G334 T333 
V305 R335 
'IMP 
G306 
R304 1307 
"G308 
Fig. 4. Stereo view of the superposition of active sites from chains A and B of the IMP 
complex. Chains A and B are superimposed showing conformational differences in the IMP 
complexes of the two subunits. Thin and bold lines represent chains A and B, respectively, 
of the IMP complex. See Results for further details. 
Fig. 5. Stereo view of the GDP/6PIMP complex in the absence of hadacidin. One 
molecule of 6PIMP and one of GDP bind to each subunit (top). Electron density is from an 
omit map (coefficients of 2Fobs-Fcaic, a^ic phases) contoured at 3a using a cutoff radius of 1 
Â. Dashed lines represent donor-acceptor interactions and coordinate bonds to the Mg2+ in 
the bottom panel. Additional details are in the Results. 
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6PIMP 6PIMP 
Fig. 6. Stereoview of the 6PIMP/GDP/hadacidin complex. One molecule of 6PIMP, GDP 
and hadacidin bind to the single, symmetry-unique subunit in this crystal form (top). 
Electron density is from an omit map (coefficients of 2F0bs-Fcaic, ctcaic phases) contoured at 3a 
using a cutoff radius of 1 Â. Dashed lines represent donor-acceptor interactions. Only the 
new interactions, relative to GDP/6PIMP complex, are shown. Additional details are in the 
Results. 
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chapter 4. feedback inhibition and product complexes 
of recombinant mouse-muscle adenylosuccinate 
synthetase 1 
A paper submitted to the Journal of Biological Chemistry 
Cristina V. Iancu, Tudor Borza, Herbert J. Fromm, and Richard B. Honzatko2 
Abstract 
Adenylosuccinate synthetase governs the committed step of AMP biosynthesis: the 
generation of 6-phosphoryl-IMP from GTP and IMP, followed by the formation of 
adenylosuccinate from 6-phosphoryl-IMP and L-aspartate. The enzyme is subject to 
feedback inhibition by AMP and adenylosuccinate, but crystal lographic complexes of the 
mouse-muscle synthetase presented here infer mechanisms of inhibition that involve 
synergistic ligand combinations. AMP alone adopts the productive binding mode of IMP, 
and yet stabilizes the active site in a conformation that favors the binding of Mg2+-IMP to the 
GTP pocket. On the other hand, AMP, in the presence of GDP, orthophosphate and Mg2*, 
adopts the binding mode of adenylosuccinate. Depending on circumstances then, AMP 
behaves as an analogue of IMP or as an analogue of adenylosuccinate. The complex of 
adenylosuccinate/GDP/Mg2>/sulfate, the first structure of an adenylosuccinate-bound 
synthetase, reveals significant geometric distortions, tight non-bonded contacts, and a 
probable state of protonation for adenylosuccinate consistent with the formation of a C-6 
purine cation. To a first approximation, adenylosuccinate forms from 6-phosphoryl-IMP and 
L-aspartate by the movement of the purine ring into a stationary a-amino group of L-
aspartate. 
Introduction 
Adenylosuccinate synthetase [IMP: L-aspartate ligase (GDP-forming), EC 6.3.4.4] 
catalyzes the first committed step in AMP biosynthesis from IMP. The reaction for 
synthetases from Escherichia coli and mouse-muscle (and presumably all other synthetases 
as well) occurs in two stages: First, the y-phosphoryl group of GTP is transferred to the 0-6 
atom of IMP, forming 6-phosphoryl-IMP (6PIMP1). Second, the a-amino group of L-
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aspartate displaces the 6-phosphoryl group of 6PIMP to form adenylosuccinate (SAMP) (1-
7). Data from isotope scrambling experiments support the formation of 6PIMP as an 
enzyme-bound intermediate (4), and indeed, 6PIMP appears at the active site in crystal 
structures of the E. coli and mouse-muscle synthetases (7,8). The kinetic mechanism is 
random sequential with a strong bias in favor of the association of L-aspartate after the 
formation of an enzyme/IMP/GTP complex (9). The synthetase requires Mg2+, but Ca2> or 
Mn2v also support catalysis, albeit at lower rates (1,2,10). Synthetases are subject to several 
possible mechanisms of metabolite regulation in vivo: inhibition of the E. coli synthetase by 
stringent effectors, such as guanosine 3-diphosphate 5'-diphosphate (11-12), substrate 
inhibition of the mouse-muscle enzyme by high concentrations of IMP (13-15), and feedback 
inhibition by AMP of synthetases in general (1,2,16). 
Although crystal structures of the synthetase with AMP (17), IMP (8, 18) or 6PIMP 
(7,8) are in the literature, complexes with adenylosuccinate or L-aspartate are unavailable. In 
fact, crystalline complexes with hadacidin (5,7,11,18-19) or a hadacidin-related derivative 
(19) provide the only basis for modeling interactions between L-aspartate and the active site. 
Hadacidin (Af-formyl-N-hydroxyglycine) is a competitive inhibitor with respect to L-aspartate 
(Kj~10'6 M) (20), but does it faithfully represent interactions of the true substrate? The N-
hydroxyl and /V-formyl groups of hadacidin together are similar in charge and 
stereochemistry to a protonated a-carboxyl group of L-aspartate (3). Hence, hadacidin is like 
the mono-anionic form of succinate. In complexes of hadacidin, the /V-hydroxyl group 
hydrogen bonds with an aspartyl side chain essential for catalysis (Asp13 and Asp43 in E. coli 
and mouse-muscle synthetases, respectively). An unprotonated oxygen atom from the a-
carboxyl group of L-aspartate, however, cannot hydrogen bond with this aspartyl side chain. 
Either the active site has different conformations in its hadacidin and L-aspartate complexes 
or an additional co-factor (metal cation or proton) must stabilize the interaction between the 
aforementioned carboxyl groups (3). 
On the basis of model building, the P-carboxyl group of L-aspartate may have a 
catalytic function in abstracting a proton from the a-amino group of L-aspartate and in 
orienting the lone-pair orbital of the a-amino group toward the C-6 atom of IMP (3,5). This 
putative catalytic role for the P-carboxyl group may account for the absence of measurable 
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synthetase activity with other amino acids such as glycine, serine, and asparagine. On the 
other hand, hydroxy lamine is a substrate of the synthetase (22,23), and in a buffer system of 
comparable ionic strength, supports a maximal catalytic rate comparable to that of L-aspartate 
(Underbakke and Honzatko, unpublished). Hence, the participation of the P-carboxyl group 
of L-aspartate as a base catalyst is at best speculative. 
The mechanism of feedback inhibition of the synthetase by AMP is also not fully 
resolved. Only a single AMP complex is available for the E. coli enzyme (17), and in that 
complex the enzyme itself is modified near the active site by an adduct of 2-mercaptoethanol. 
Potent inhibition of the synthetase generally involves synergistic combinations of two or 
more ligands. For instance, nitrate enhances inhibition by GDP (5,24) and GDP/Pi enhances 
inhibition by hydantocidin 5-phosphate (19,25). A complex of AMP alone then may not 
provide a comprehensive model for feedback inhibition of the synthetase. 
Presented here are crystal structures of recombinant mouse-muscle adenylosuccinate 
synthetase in complexes with AMP alone (AMP complex), AMP/GDP/Pj/Mg2* 
(AMP/product complex) and SAMP/GDP/S042"/Mg2+ (SAMP/product complex). The first 
two complexes reveal distinct binding modes for AMP and suggest the possibility of 
AMP/IMP and AMP/GDP/P, binding synergies. The SAMP/product complex offers the first 
instance of an enzyme active site ligated by SAMP. The succinyl moiety of SAMP occupies 
the hadacidin pocket, but requires no additional metal ion to facilitate interactions involving 
its "a"-carboxyl group. Moreover, interactions at the active site are indicative of a 
mechanism that stabilizes the formation of a cationic form of 6PIMP prior to the nucleophilic 
attack of L-aspartate. 
Materials and Methods 
Materials— Magnesium sulfate and magnesium acetate came from Fisher, all other reagents 
were from Sigma. 
Purification and Crystallization of the Recombinant Mouse Muscle Isozyme— The enzyme 
was prepared as described previously (26) and was at least 95% pure on the basis of SDS-
polyacrylamide gel electrophoresis. Crystals were grown by the method of hanging drops. 
Wells contained 500 pL of precipitant solution and droplets had equal volumes (3 |iL) of 
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protein and precipitant solutions. The protein solution (10 mgZmL enzyme in 50 mM Hepes, 
pH 7, 50 mM NaCl, 1 mM dithiothreitol, and 0.5 mM EDTA) contained AMP (10 mM and 5 
mM in the AMP and AMP/product complexes, respectively), GDP (5 mM in AMP/product 
and SAMP/product complexes), potassium phosphate (25 mM in the AMP/product complex), 
SAMP (10 mM in the SAMP/product complex), magnesium acetate (10 mM in both the 
AMP and AMP/product complexes) and/or magnesium sulfate (15 mM in the SAMP/product 
complex). The precipitant solution contained 100 mM Hepes, pH 7, polyethylene glycol 
8000 and 200 mM magnesium acetate (for both the AMP and AMP/product complexes) or 
100 mM magnesium sulfate (for the SAMP/product complex). Prisms of equal dimensions 
appeared in the following concentrations of polyethylene glycol 8000:16% (w/v) for the 
AMP complex, 19% (w/v) for the AMP/product complex and 14% (w/v) for the 
SAMP/product complex. Crystals were transferred to cryogenic solutions as described 
previously (26). The final cryogenic solution contained 21% (v/v) glycerol and equal parts 
of the above protein solution (less the protein) and the precipitant solution. 
Data Collection— All data sets were collected on a Rigaku R-AXIS IV++ image-plate 
detector, using an Osmic confocal mirror system (CuK* radiation), and a sample temperature 
of 100 K. Data reduction employed CrystalClear software. 
Model Refinement— Initial phases for all complexes reported here came from molecular 
replacement, using the 6PIMP/GDP/hadacidin complex of the mouse-muscle synthetase 
(PDB accession label ILON), without ligands and water molecules. Models representing the 
ligands were fit to omit electron density maps using XTALVIEW (27). Refinement of the 
model, following protocols described previously (26), employed CNS (28). Force constants 
and parameters of stereochemistry came from Engh and Huber (29). Estimates of coordinate 
error used the method of Luzzati (30). Stereochemistry of the refined models was analyzed 
by PROCHECK (31). Superpositions of structure were done with software from the CCP4 
package (32). 
Results 
Statistics of data collection and refinement are in Table I. The AMP, AMP/product, and 
SAMP/product complexes have nominal resolutions of 2.7, 2.5, and 2.4 Â, respectively. All 
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crystals belong to the space group P4]2,2, and are isomorphous, having but one subunit of 
the synthetase dimer in the asymmetric unit. In all structures, electron density is present for 
the whole sequence save the first 26 amino acid residues of the N-terminus. Stereochemistry 
of the refined models is as good as or better than models derived from data of comparable 
resolution. No residues fall in un allowed regions of the Ramachandran plot, and 
approximately 90% of all residues lie in most favorable regions. Thermal parameters vary 
from 27-100, 19-75, and 15-88 À2 for the AMP, AMP/product, and SAMP/product 
complexes. Root-mean-squared deviations in corresponding Ca atoms are less than 0.5 À 
for superpositions of each of the complexes onto the 6PIMP/GDP/hadacidin complex of the 
mouse-muscle synthetase (PDB accession label ILON). 
The active site of the synthetase has six dynamic components, which are in ligated or 
ligand-free conformations, or are disordered, depending on the presence of specific ligands 
and conditions of crystallization (8,26). The unligated structure of the mouse-muscle 
synthetase (PDB accession label 1J4B) defines the ligand-free conformations of these 
dynamic components, whereas the 6PIMP/GDP/hadacidin complex (PDB accession label 
ILON) defines their ligated conformations. All dynamic components in the complexes 
reported here lie in strong electron density. Figure 1 provides an overview of the 
SAMP/product complex and defines the dynamic elements of the synthetase. The Switch 
loop (residues 70-83), the IMP loop (residues 152-165), the GTP loop (residues 448-452), 
and the Val loop (residues 304-310) are in their ligated conformations. The pre-Switch 
element (residues 65-69) is in its ligated conformation or nearly so. Small but significant 
variations in conformation of the pre-Switch element are discussed thoroughly below. The 
Asp loop (residues 330-336) is in its ligand-free conformation in the AMP and AMP/product 
complexes, and in its ligated conformation in the SAMP/product complex. 
AMP Complex— The IMP pocket and the P-phosphoryl site of the GDP pocket have 
appreciable electron density in omit maps. The electron density at the IMP pocket is 
consistent with a molecule of AMP (Fig. 2). The electron density associated with the P-
phosphoryl site of GDP is probably an acetate molecule, given the following observations: (0 
The thermal parameter of a water molecule refined at the P-phosphoryl site is approximately 
one-half the value of thermal parameters for nearby atoms of the protein, whereas the thermal 
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parameters for an acetate molecule are comparable to those of nearby atoms, ( i t )  The mouse-
muscle IMP complex (PDB accession label 1IWE; resolution of 2.1 Â) has electron density 
at the P-phosphoryl site of GDP that clearly represents a bound acetate molecule (8). 
The 5'-phosphoryl group of AMP interacts with the backbone amide and side chain 
of Thr163 and with the side chains of Asn68, Arg177# and Thr271. (Arg177* comes from the 
symmetry-related subunit of the dimer). The 2'-hydroxy 1 group, N-7 atom and 6-amino 
group of AMP hydrogen bond with backbone carbonyl 305 (Val loop), the side chain of 
Asn256 and backbone carbonyl 69 (part of the pre-Switch loop), respectively. The pre-S witch 
loop is almost in its ligated conformation (as defined by the 6PIMP/GDP/hadacidin 
complex), but peptide linkages between residues 68-70 have significantly different 
orientations (see below). One oxygen atom of Asp43 is 3.4 Â from the N-l atom of AMP. 
As neither the N-l atom nor Asp43 should be protonated at pH 7, this interaction is probably a 
non-bonded contact rather than a hydrogen bond. 
AMP/product complex— Electron density from omit maps is consistent with bound AMP, 
GDP, Mg2+ and Pi (Fig. 3). Protein interactions with GDP are identical to those reported 
previously in other mouse-muscle complexes (PDB accession labels ILNY and 1LON). 
Mg2+ coordinates oxygen atoms, a total of six, from backbone carbonyl 70, Asp43, P., the 
phosphoryl groups of GDP and a water molecule (Fig. 3). The water molecule is 2.8 Â from 
the Mg2\ and also hydrogen bonds with Arg337. The oxygen atom from Asp43, on the other 
hand, has a coordination distance to the Mg2+ of 2.0 Â. These coordinate and hydrogen 
bonds are of significance to the proposed mechanism of the synthetase, discussed below. 
The Pi molecule, in addition to its coordination with Mg2+, hydrogen bonds with backbone 
amides 43, 70, and 256, with the side chains of Lys46, His7' and Asn256, and with the 6-amino 
group of AMP (Fig. 3). 
Although interactions at the 5" -phosphoryl group of AMP are identical in the AMP 
and AMP/product complexes, the presence of Pi, Mg2+ and GDP alters the interactions at the 
base of AMP. By coordinating to Mg2\ the side chain of Asp43 moves toward the N-l atom 
of AMP. Both oxygen atoms of the aspartyl side are approximately 3.0 Â from atom N-l. 
These contacts, however, for reasons noted above, are probably not hydrogen bonds. The 
coordination of backbone carbonyl 70 to Mg2*" evidently triggers a rotation of 180° in the 
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peptide linkage between residues 69 and 70. The pre-Switch loop (residues 65-69) is now in 
its ligated conformation. Consequently, backbone carbonyl 69 no longer hydrogen bonds 
with the 6-amino group of AMP (as observed in the AMP complex above), being replaced 
instead by backbone carbonyl 68. The side chain of Asn68 also shifts by -1 À, but retains its 
hydrogen bond with the 5'-phosphoryl group of AMP. In order to avoid a close contact with 
the Pi molecule, the entire base of AMP tilts some 25° relative to that observed in the AMP 
complex. As a consequence, Asn256 no longer hydrogen bonds with the N-7 atom of AMP. 
Furthermore, the 2-hydroxyI group of AMP hydrogen bonds with backbone amide 306, 
instead of backbone carbonyl 305, as in the AMP complex. In fact, the peptide link between 
residues 305 and 306 has undergone a rotation of-180°. 
SAMP/product Complex— Electron density from omit maps is consistent with bound GDP, 
SO42" (at the 6-phosphoryl site of 6PIMP), Mg2+, and SAMP at the active site (Fig. 4). All 
dynamic loops adopt their ligated conformations. Interactions involving GDP. SO42-, Mg:+, 
and the AMP moiety of SAMP are identical to those above for the AMP/product complex. 
(The sulfate anion adopts all of the interactions of P; in the AMP/product complex). The tilt 
of the base moiety of SAMP (-30°) is approximately the same as that observed for the base 
of AMP in the AMP/product complex. Interactions involving the succinyl moiety of SAMP 
maintain the ligated conformation of the Asp loop. One of the oxygen atoms of the "P"-
carboxyl group of SAMP hydrogen bonds with the side chains of Arg335 and Thr333, whereas 
the other oxygen atom interacts with backbone amides 331, 332 and 333. One of the oxygen 
atoms of the "a"-carboxyl group of SAMP coordinates to Mg2+, while the other oxygen atom 
hydrogen bonds with the side chain of Arg337 and backbone amide 331. 
In spite of restraints, the base moiety of SAMP, deviates from planarity. Viewed 
"edge-on" as in Figs. 4&5, the tilt of the purine base from its 6PIMP to its SAMP position is 
the combination of a geometric distortion (bending of the purine ring) and a rigid-body 
rotation of the entire nucleotide. The modest resolution of the SAMP/product complex does 
not allow the assignment of geometric distortions with certainty to any particular subset of 
atoms, but the displacement of atom C-6 from the plane defined by atoms N-l, N-6 and C-5, 
is evident (Fig. 4). The bending of the base moiety of SAMP is opposite to that of 6PIMP, 
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whereas the base moiety of the nucleotide in the AMP complex takes up an intermediate 
position. 
Close non-bonded or hydrogen-bonded contacts involving the SAMP molecule are 
clearly in evidence. Oxygen atoms of the "a"-carboxyl group have contacts of 
approximately 2.6 and 2.8 Â with the N-6 and CP atoms, respectively, of SAMP. Perhaps of 
greater significance is the aberrant donor-acceptor distance of 2.2 Â between the 2'-hydroxy! 
group of SAMP and backbone carbonyl 305. Several alternative models were built and 
refined here: The rotation of the peptide linkage between Val305 and Gly306 removed the close 
donor-acceptor distance, but introduced a non-bonded contact of 2.4 Â between backbone 
carbonyls 305 and 306, and significant electron difference density in proximity to the 2'-
hydroxyl group of SAMP. Rotations about the Ca-CP bond of Val305 had no appreciable 
effect, and the conformation of the ribosyl moiety of SAMP (2'-endo) already maximized the 
donor-acceptor distance in question. Backbone carbonyls of the Val loop (residues 304-310) 
and the 2'- and 3-hydroxyI groups of SAMP fall into distinct electron density in omit maps, 
and furthermore, the electron density between the 2-hydroxy! group and backbone carbonyl 
305 is continuous at a contour level of la. The significance of geometric distortions and 
close contacts involving SAMP is discussed below. 
In models of the active site, the side chain of Asp43 (Asp13 in the E. coli synthetase) 
makes a close contact with the a-carboxyl group of l-aspartate (5). In the SAMP/product 
complex, however. Asp43 has acceptable non-bonded contacts with the "a"-carboxyl group 
of SAMP of no less than 3 Â. Instead, the oxygen atom of Asp43 that coordinates Mg2> 
(coordination distance now increased to 2.4 À) makes a contact of 2.6 À with the N-l atom 
of SAMP. As the ligands are all in strong electron density, the short contact distance above 
infers a hydrogen bond, and a proton associated with either the N-l atom of SAMP or the 
oxygen atom of Asp43. The state of protonation of the N-l atom of SAMP is significant to 
the catalytic mechanism, as discussed below. 
Discussion 
The AMP complex of the E. coli enzyme, which crystallized from sodium acetate, has a 
water molecule assigned to the P phosphoryl site of the GTP pocket (17). The thermal 
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parameter of that "water molecule" is approximately one-half of those of nearby atoms of the 
protein, and is probably an acetate molecule, as assigned here in the mouse-muscle complex. 
The 5-phosphoryl group, the 2'-hydroxyl group, the N-7 atom and the 6-amino group of 
AMP have equivalent hydrogen bonds in the £. coli and mouse-muscle complexes. The pre-
Switch loops of the mouse-muscle and £. coli synthetases are in the same conformation, and 
maintain the same hydrogen bonds with AMP. In the £. coli AMP complex, the Asp loop 
(residues 298-304) has inflated thermal parameters and may be disordered, whereas the Asp 
loop (residues 330-336) of the mouse-muscle AMP complex is in its ligand-free 
conformation, well removed from the active site. Although the 2-mercaptoethanol adduct of 
Cys291 of the £. coli enzyme may influence the dynamics of its Asp loop and perhaps be a 
factor in lattice contacts, its effect on AMP-ligation seems insignificant. 
The AMP-complex of the mouse-muscle synthetase has AMP bound in the 
productive binding mode of IMP (chain A of PDB accession label 1IWE), and yet the pre-
Switch loop adopts the conformation observed in the nonproductive binding mode of IMP 
(chain B of PDB accession label 1IWE). Backbone carbonyl 69 hydrogen bonds with the 6-
amino group of AMP, whereas that same carbonyl forces the base moiety of IMP out of its 
pocket, presumably in order to relieve an unacceptable contact with the 0-6 atom. In fact, 
AMP could enhance the binding of Mg2+-IMP to the OTP pocket. When IMP binds 
productively, Mg2+-IMP does not bind to the GTP pocket (chain A of PDB accession label 
1IWE), but when IMP binds nonproductively Mg2+-IMP fully occupies the GTP pocket 
(chain B of PDB accession label 1IWE). Hence, the non-productive binding of IMP and the 
binding of Mg:+-IMP to the GTP pocket may be correlated phenomena. As the "AMP" and 
"non-productive IMP" conformations of the pre-Switch loop are identical, the binding of 
AMP to the IMP pocket may favor the binding of Mg2+-IMP to the GTP pocket. In 
exhaustively exercised muscle, IMP concentrations rise (14), so that AMP/IMP binding 
synergism, if it were to occur as described above, could limit synthetase activity in muscle 
under conditions of vigorous exercise. 
GDP, Pi and Mg2+ alter the binding of AMP and the conformation of the pre-Switch 
loop. The conformation of the protein in the AMP/product complex is identical to that of the 
6PIMP/GDP complex (PDB accession label 1LNY), even though recognition of the base 
71 
moieties of AMP and 6PIMP differ substantially. The hydrogen bond between the 6-amino 
group of AMP and Pj (as opposed to the corresponding covalent bond in 6PIMP) forces the 
base of AMP to tilt some 25°out of the space occupied by the base of 6PIMP. As a 
consequence, Asn256 cannot hydrogen bond with the N-7 atom of AMP in the AMP/product 
complex. In fact, AMP in the presence of GDP/Pi/Mg2+ binds as an analogue of SAMP, 
whereas AMP alone binds as an analogue of IMP. The crystallographic data here do not 
prove AMP-related binding synergism, but suggest it as a possibility, particularly given 
previous accounts of binding synergies involving the synthetase. The origin of potent 
inhibition (Kj~l0 8 M) by hydantocidin 5'-phosphate in the presence of GDP, Pj and Mg2+ 
(19, 25), for instance, is due largely to interactions of the "base moiety" of the inhibitor with 
Pi, which in turn interacts with GDP through a coordinating Mg2+ (19). The smaller base of 
hydantocidin 5-phosphate (relative to that of AMP) can adopt the productive binding mode 
of IMP (base tilt angle of 0°), which not only allows hydrogen bonds with Pi, but also with 
side chains that usually recognize the N-7 and N-l positions of the purine base. 
The SAMP/product complex provides a definitive starting point for the reverse 
reaction governed by the synthetase (formation of 6PIMP and l-aspartate from P. and 
SAMP). Foremost amongst considerations, is the state of protonation of SAMP. In the 
AMP/product complex, Asp43 tightly coordinates Mg2> (bond distance of ~2 À), and 
distances between the oxygen atoms of Asp43 and the N-l atom of AMP are -3 Â, consistent 
with close, but allowable, non-bonded contacts. On the other hand, the coordinate bond of 
Asp43 to Mg2+ increases to 2.4 À in the SAMP/product complex, while the distance of the 
coordinating oxygen to the N-l atom of SAMP decreases to 2.6 Â. In fact, all relevant 
complexes of mouse-muscle and E. coli synthetases taken together (5,7-8,11,18) reflect 
competition between Mg2+ and the N-l atom of the purine base in binding to Asp43 (Asp13 in 
the E. coli synthetase). Evidently, the SAMP/product complex favors a hydrogen bond 
between Asp43 and the N-l atom of SAMP. Hence, a proton could reside at least fractionally 
on the N-l atom of SAMP (Fig. 6). 
Electronic resonance will de-localize the positive charge of the protonated N-l atom 
into the adjacent C-6 atom of the purine base (Fig. 6). In contrast, the C-6 to N-6 torsion 
angle of SAMP, with a value of -68°, prevents de-localization of electrons from the lone pair 
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orbital of the N-6 atom into the electron deficient C-6 atom. Such electronic de-localization 
is appreciable only if the C-6 to N-6 torsion angle is near 0 or 180°. The nearby phosphate 
anion (a sulfate anion in the SAMP/product complex) should further stabilize positive charge 
at the C-6 atom. Interactions at the active site of the synthetase then probably enrich the C-6 
cationic form of SAMP. 
In addition to electronic factors, the distortion imposed by the synthetase on the 
purine ring increases the energy of SAMP in its ground-state complex. The distortion of the 
purine ring probably disappears in the intermediate tilt position, as observed in the AMP 
complex. Hence, the energy penalty associated with the geometric distortion in the ground-
state complex of SAMP probably does not carry over to the transition sate. The geometric 
distortions in the purine base evidently cannot relax by a rigid-body motion of the 
phosphoribosyl moiety of SAMP; the tight, donor-acceptor contact between the 2'-hydroxy 1 
group of SAMP and backbone carbonyl 305 blocks that relaxation pathway. 
Once the synthetase generates the 6-cationic form of SAMP, the geometric 
relationship of functional groups dictates the course of the reaction. An oxygen atom of 
SO42" (as an analogue of Pi) is -2.8 Â from the C-6 atom of SAMP. Furthermore, the vector 
from the C-6 atom to that oxygen atom is perpendicular to the plane of the purine ring (Fig. 
7). The above represents ideal geometry for a reaction between an sp1 cation and an 
approaching nucleophile. The reaction coordinate is the change in tilt angle of the base 
moiety from that of SAMP (-30°) to that of 6PIMP (0°). Neither the Pi molecule nor the 
aspartyl moiety need move in forming 6PIMP from SAMP. The a-amino group of L-
aspartate would be -2.7 À from the C-6 atom of 6PIMP at the end of the reaction; the vector 
from the C-6 atom of 6PIMP to the a-amino group of L-aspartate would be perpendicular to 
the purine ring (Fig. 7). One of the two hydrogen atoms attached to the a-amino group of L-
aspartate probably hydrogen bonds with backbone carbonyl 68, while the other lies between 
oxygen atoms (one from the 6-phosphoryl group of 6PIMP and the other from the a-carboxyl 
group of L-aspartate), coordinated to the active site Mg2>. 
A proton transfer to the N-6 atom is necessary during the transition state. The source 
of that proton is unsettled, although two oxygen atoms of P, offer proton binding sites less 
than 2 Â from the N-6 atom of SAMP. The "P"-carboxyl group of SAMP is not positioned 
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favorably for the delivery of a proton to the N-6 atom. Hence, a direct catalytic role for the 
P-carboxyl group of L-aspartate (5) is not supported by these data. 
Asp43 presumably maintains its hydrogen bond with the N-l atom throughout the 
transition from SAMP to 6PIMP. In 6PIMP/GDP/hadacidin complexes of the mouse-muscle 
and E. coli synthetases, however, the catalytic aspartate does not hydrogen bond with the N-1 
position of the purine base, instead being tightly coordinated to the Mg2+ (7,8). The N-
hydroxyl group of hadacidin, which hydrogen bonds with the oxygen atom of Asp43 not 
coordinated to Mg2+, may draw the side-chain of the catalytic aspartate from the N-l atom of 
6PIMP. Indeed, Asp43 is closer to the N-1 atom of 6PIMP in the absence of hadacidin than in 
its presence, although not so close as to provide unambiguous evidence for the formation of a 
hydrogen bond (7,8). Short of such evidence, we can only suspect that the ligation of L-
aspartate to the active site stabilizes a hydrogen bond between Asp43 and the N-l atom of 
6PIMP. 
The structural data imply a precisely tuned set of interactions that allow Mg2+ to 
modulate the acid/base properties of Asp43 (Asp13 in the E. coli synthetase) in the sequence of 
reactions catalyzed by the synthetase. During the first step of the forward reaction, the 
catalytic aspartate may be more than 3 Â from the Mg2\ and hydrogen bonded with the N-l 
atom of IMP (5). By abstracting the proton from the N-l atom, the catalytic aspartate would 
generate the 6-oxyanion of IMP. The 6-oxyanion would attack the ^-phosphoryl group of 
GTP and displace GDP (5). After formation of 6PIMP, the catalytic aspartate moves close to 
(-2.4 A away from) the Mg2+, becomes a strong acid, and transfers its proton back to the N-l 
position of 6PIMP. Electronic resonance will de-localize the positive charge at the 
protonated N-l atom of 6PIMP into its C-6 atom. The amino group of L-aspartate, then 
displaces the 6-phosphoryl group from 6PIMP to produce SAMP. 
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Table I. Statistics of data collection and refinement. 
AMP AMP/product SAMP/product 
complex complex complex 
Data reduction: 
Space group P432,2 P432,2 P432,2 
Unit cell parameters #=6=70.24, a=6=70.60. <2=6=70.63, 
c=l99.14 c=198.39 c= 196.71 
Resolution limit (À) 49.7-2.7 48.3-2.5 35.3-2.4 
No. of reflections 152,538 101,321 148,956 
No. of unique reflections 14.742 18,245 20,266 
Completeness of data (%) 
Overall 99.5 99.7 98.4 
Last shell 99.9 100 99.7 
(2.8-2.7 Â) (2.6-2.5 Â) (2.5-2.4 Â) 
R a Emerge 
Overall 0.062 0.074 0.056 
Last shell 0.330 0.341 0.272 
Refinement: 
No. of reflections'1 13,936 17,563 19,758 
No. of atoms 3418 3517 3527 
No. of solvent sites 38 107 109 
RC/Rfr==d 0.231/0.297 0.216/0.291 0.225/0.282 
Mean B for protein (À2) 
Main chain 52 41 43 
Side chain 55 42 44 
Root mean square 
deviations 
Bond length (À) 0.007 0.006 0.008 
Bond angles (°) 1.3 1.3 1.5 
Dihedral angles (°) 23.0 23.0 23.5 
Improper dihedral angles 
(°) 0.85 0.83 1.4 
aRmerge = ZjZi|Iij-<Ij>|/ZiZj Iij, where i runs over multiple observations of the same 
intensity and j runs over crystallographically unique intensities. 
bAll unique data above 15 À resolution and having F > 2<Tf-
cR-factor = Z||F0bs|-|Fca,c||/Z|F0bs|, |Fobs|>0. 
dR-factor based upon 10% of the data randomly culled and not used in the refinement. 
Si C-icr 
Src-Swiich 
I loop 
Switch 
loop 
Fig. 1. Stereo view of a single subunit of the mouse muscle isozyme in its fully ligated 
conformation. Bold lines delineate the pre-Switch (residues 65-69), Switch (residues 70-
83), IMP (residues 152-165), Val (residues 304-310), Asp (residues 330-336) and GTP 
(residues 448-452) loops. Ligands (labeled GDP, SAMP and S04, the latter for the sulfate 
anion) are in wire frame representation. A filled circle (labeled Mg) represents the site of 
Mg:> binding. This figure was drawn with MOLSCRIPT (33). 
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R177# 
N256 
R177» 
Fig. 2. Stereoview of AMP bound to the active site. Electron density is from an omit map 
(coefficients of 2Fobs-Fcaic, Ckaic phases) contoured at 3ct using a cutoff radius of 1 Â. Dashed 
lines represent donor-acceptor interactions. 
Fig. 3. Stereoview of AMP/product complex. Electron density covering AMP, 
orthophosphate (labeled PJ, Mg2*, and GDP is from an omit map (coefficients of ZFobs-Fcaic, 
Ovale phases) contoured at 3a using a cutoff radius of 1 Â (top). Dashed lines represent 
donor-acceptor interactions and coordinate bonds to the Mg2+ (bottom). 
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R177» R177» 
AMP d / il AMP 
Z&k V .^3b 5F \ —-\£r V 
R177» R177S 
81 
R337 
'SAMP 'SAMP 
Fig. 4. Stereoview of SAMP/product complex. Electron density covering SAMP is from an 
omit map (coefficients of 2F0bs-Fcaic, Ocaic phases) contoured at 3a using a cutoff radius of 1 
Â. Dashed lines represent donor-acceptor interactions and coordinate bonds to the Mg2+. 
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6PIMP iAMP 
Fig. 5. Definition of the tilt angle of the base moiety. The alignment of 6PIMP and SAMP 
(bold lines) comes from the superposition of Ca coordinates of the 6PIMP/GDP/hadacidin 
complex (8) and SAMP/product complex. The base moiety of 6PIMP defines a tilt angel of 
zero degrees. 
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SAMP N Mg! 
^ n h—6 
>-O Asp 43 
SAMP N 
-T> 
,s 
Mg2' 
I 
t 
N—H—- 6 
q Asp 43 
SAMP N* 
, N—H--
Mg2* 
I I 
--6" 
0/ Asp 43 
Fig. 6. Proton exchange and electronic resonance of SAMP in its ground-state complex. 
See text for details. 
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L-Aspartate 
'SAMP 6PIMP 
Fig. 7. Geometric relationships in the reverse reaction for the conversion of SAMP to 
6PIMP. Superposition of Ca atoms of the 6PIMP/GDP/hadacidin complex (8) onto the 
SAMP/product complex determines the relative positions and orientations of 6PIMP, SAMP 
and Pj. (Pj takes the position of the sulfate anion in the SAMP complex). The transition state 
geometry is in square brackets: the nucleotide shown there comes from the AMP complex, 
less the N-6 atom. The orientation and position of the transition-state nucleotide is 
determined by the superposition of the Ca atoms of the AMP complex onto the 
SAMP/product complex. Numbers indicate distances in units of À. 
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chapter 5. anion- and cation-induced conformational 
change in recombinant mouse-muscle and ESCHERICHIA 
COU adenylosuccinate synthetases 
A paper to be submitted to the Journal of Biological Chemistry 
Cristina V. Iancu, Tudor Borza, Jun-Yong Choe, Herbert J. Fromm, and Richard B. 
Honzatko 
Abstract 
Adenylosuccinate synthetase participates in the de novo biosynthesis of AMP and is 
one of three enzymes of the purine nucleotide cycle. Conformational changes in as many as 
six loops attend ligand-association with synthetases. GDP- and IMP-ligated complexes of 
the mouse muscle and Escherichia Coli systems, which differ only in the type of anion 
(SO42™, Cl~, acetate) or cation (Mg2* or Li*) present in their crystallization milieus, exhibit 
significant conformational differences. IMP and acetate stabilize an ordered active site in the 
mouse muscle synthetase, but IMP and Cl~ result in a disordered active site. Sulfate anions 
bind to the phosphoryl sites of 6-phosphoryl IMP in the presence of Mg2* and GDP, but not 
in the presence of Li* and GDP. In the presence of LiiSOj, GDP alone stabilizes a ligated 
conformation of an important dynamic loop (Switch loop) in the mouse muscle and E. coli 
enzymes. In conjunction with previous results, data here are consistent with the following: 
IMP requires a bound anion to the ^-phosphoryl pocket of GTP in order to organize the 
active site. Mg2* may bind preferentially to an active site ligated by both GDP (or GTP) and 
IMP, and does not bind as a stoichiometric complex of Mg2*/GTP. Conformational 
differences, exhibited by synthetases in single-ligand complexes of IMP or GDP, are largely 
due to subtle variations in crystallization conditions, rather than to intrinsic differences in the 
protein 
Introduction 
Adenylosuccinate synthetase [IMP:L-aspartate ligase (GDP-forming), EC 6.3.4.4] catalyzes 
the first committed step in the de novo biosynthesis of AMP (See 1—3 for reviews). The 
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synthetase catalyzes the nucleophilic attack of the 6-oxo group of IMP on the ^-phosphoryl 
group of GTP to form 6-phosphoryl-IMP (6PIMP) and GDP. The a-amino group of L-
aspartate then displaces the 6-phosphoryl group of the intermediate to form adenylosuccinate 
(3). The synthetase requires a divalent cation. Mg2+ supports catalytic rates approximately 
8-fold higher than either Ca2+ or Mn2+( 1,2,4). The kinetic mechanism is random sequential 
with a strong bias in favor of the association of L-aspartate after the formation of an 
enzyme/IMP/GTP complex (5,6). Data from isotope exchange kinetics support the formation 
of 6PIMP as an enzyme-bound intermediate (7). Indeed, 6PIMP appears at the active site in 
crystal structures of the Escherichia coli and mouse muscle synthetases (8,9). 
Vertebrates possess two isozymes of the synthetase, differing with respect to their 
isoelectric points, N-terminal leader sequences, ligand sensitivities, and tissue distribution 
(10,11). The basic isozyme of the synthetase (sometimes called AdSSl or the muscle 
enzyme) may work in combination with adenylosuccinate lyase and AMP deaminase. 
Lowenstein has called this triad of enzymes the purine nucleotide cycle (12). The acidic 
isozyme (often called AdSS2 or the liver enzyme) participates in the de novo biosynthesis of 
AMP, and is probably not involved in the purine nucleotide cycle. Bacteria, such as 
Escherichia coli. typically have one form of the synthetase, which has an acidic pi. 
The active sites of ligand-free and ligated, mouse-muscle and E. coli synthetases 
exhibit significant differences in structural elements essential for catalysis (9, 13-21). The 
conformational state of the Switch loop (residues 40—53 and 70-83 of the E. coli and mouse 
muscle synthetases, respectively) has become a significant criterion in distinguishing a 
disorganized, unproductive active site from an organized active site, ready to do catalysis 
(2,3,9,16,22). In addition to the Switch loop, the IMP, GTP, Asp, pre-Switch and Val loops 
also undergo conformational changes in response to ligand association. Dynamic elements in 
their "active" (ligated) conformations appear in Fig. 1. 
As the kinetic mechanism of the synthetase is random sequential (5), the enzyme-
GTP complex must exist in solution; however, if GTP binds productively before IMP, then 
an unproductive hydrolytic reaction is likely. The synthetase can avoid the unproductive 
hydrolysis of GTP by organizing its catalytic machinery in response to the ligation of IMP 
(22). Indeed, the mouse muscle synthetase remains in its ligand-free (disorganized) 
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conformation with GDP/GTP nonproductively bound to the active site (9). Furthermore, the 
IMP complexes of the E. coli and mouse muscle synthetases have organized active sites 
(9,22). On the other hand, the observation in plant synthetases from Arabidopsis thaliana 
and Triticum aestivum of GDP-organized active sites (the Switch loop adopts its ligated 
conformation in the presence of GDP) is inconsistent with the model of an acceptor-activated 
synthetase (23). Moreover, even in the IMP complex of the mouse muscle synthetase, an 
acetate molecule binds to the fJ-phosphoryl site of the GTP pocket: Does that acetate 
molecule play a significant role in stabilizing the organized active site? 
Presented below are crystalline complexes of mouse muscle and £. coli synthetases 
that explore the effects of different anions and cations on the conformation of IMP- and 
GDP-ligated active sites. The synthetases from mouse and £. coli exhibit significant 
conformational differences in their pre-Switch, Switch, IMP, and GTP loops; these 
conformational differences stem from the choice of counter ion to the magnesium or from the 
choice of metal cation, introduced in crystallization experiments. Some of the reported 
differences in the conformational responses of synthetases from plants relative to the mouse 
muscle and £. coli systems may not be due to intrinsic differences in the proteins, but rather 
to subtle changes in the conditions of crystallization. Under conditions that most closely 
approximate those of a living cell, interactions at the 5-phosphoryl site of IMP and the p-
phosphoryl site of GTP may both be necessary in order to put the active site into a state of 
readiness. 
Materials and Methods 
Materials— Magnesium sulfate and lithium sulfate were from Fisher Scientific, all other 
reagents came from Sigma. 
Purification and Crystallization of Recombinant Adenylosuccinate Synthetases— 
Recombinant mouse muscle (basic isozyme) and £. coli adenylosuccinate synthetases were 
prepared as described previously in (21,24). The enzymes were at least 95% pure on the 
basis of SDS-polyacrylamide gel electrophoresis. Crystals were grown by the method of 
hanging drops. The wells contained 500 |iL of precipitant solution and drops had equal 
volumes (3 |iL) of the precipitant and protein solutions. The protein solution had 10 mg/mL 
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enzyme in 50 mM Hepes, pH 7.5, 50 mM NaCl, 1 mM dithiothreitol, 0.5 mM EDTA, 10 mM 
GDP(or GTP) or IMP, and 10 mM MgCh, MgSÛ4 or U2SO4. The precipitant solution 
consisted of 100 mM Hepes, pH 7.0, 100 or 200 mM metal cation salt (MgCli, MgS04 or 
LiiSOj), and polyethylene glycol 8000 (18% w/v) or 4000 (16% w/v). Crystals of the E. coli 
synthetase appeared in GDP/MgSCU (200 mM)/polyethylene glycol 8000 (hereafter the 
GDP/MgSCU complex) and in GDP/ U2SO4 (200 mM)/polyethylene glycol 8000 
(GDP/L12SO4 complex). Crystals of the mouse basic synthetase appeared in 
GDP/MgSO4(l00 mM)/polyethylene glycol 4000 (GDP/MgS04 complex), GDP/LiiSO; (200 
mM)/polyethylene glycol 4000 (GDP/Li%S04 complex) and IMP/MgCh(200 
mM)/polyethylene glycol 4000 (IMP/MgCh complex). Crystals were transferred in steps, as 
described previously (21), to a cryogenic solution, containing 22% (w/v) glycerol and equal 
parts of the above protein solution (less the protein) and the precipitant solution. 
Data Collection— Data for IMP/ MgCh complex were collected at the Structural Biology 
Center (SBC) Beamline 19-BM of Argonne National Laboratory, using the SBC-2 CCD 
detector. Data for GDP/ LiiSCU complex were collected at Beamline 9-5 of Stanford 
Synchrotron Radiation Laboratory, using the CCD detector, ADSC Quantum 4. The 
wavelength of x-radiation was 0.979 Â. Data reduction was done with Denzo/Scalepack 
package (25). The other data sets were collected on a Rigaku R-AXIS IV++ system equipped 
with image plate detector and Osmic confocal optics that provided CuKa radiation. The 
temperature of data collection was 100 K. Data processing was done with CrystalClear 
software (26). 
Model Building and Refinement— The crystal forms obtained here were isomorphous to 
existing crystal forms of the E. coli and mouse basic synthetases. Hence, molecular 
replacement entailed simply the use of existing coordinate files, less ligands and water 
molecules. In the case of E. coli synthetase structures, the starting models were the fully-
ligated structure (PDB accession label 1CGO; used for GDP/MgS04 complex) and the 
hydantocidin 5 -monophosphate complex (PDB accession label ISON; used for GDP/LizS04 
complex). For all the complexes of the mouse basic synthetase, the search model was the 
fully-ligated structure (PDB accession label 1LON). Model building and refinement were 
done with the programs XTALVIEW (27) and CNS (28), respectively. Models of ligands 
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were fit to omit electron density maps. Force constants and parameters of stereochemistry 
came from Engh and Huber (29). Refinement protocols and solvent modeling are identical to 
those reported previously (22). Estimates of coordinate error used the method of Luzzatti 
(30). Evaluation of stereochemistry of the refined models employed PROCHECK (31). 
Superposition of structures used software from the CCP4 package (32). 
Results 
All ligand complexes crystallize from solutions containing Hepes buffer, pH 7. Relative to 
published crystal structures of the £. coli and mouse muscle synthetases, changes in 
crystallization conditions here are subtle: Mg(Acetate): is replaced by either MgSO.», MgCh, 
or U2SO4. GDP/U2SO4 and GDP/MgSCU complexes of £. coli synthetase diffract to 1.9 and 
2.2 À resolution, respectively. IMP/MgCh, GDP/MgSC>4 and GDP/U2SO4 complexes 
diffract to 2.3 Â, and 2.5 À resolution, respectively. Crystals of the GDP/MgS04 complex of 
the £. coli synthetase are isomorphous to those of the fully-ligated £. coli enzyme whereas 
those of GDP/U2SO4 complex are isomorphous to those of the AMP and hydantocidin 5'-
phosphate £. coli complexes (20) (Table I). Crystals of the GDP/MgS04, GDP/U2SO4 and 
IMP/MgCb complexes of the mouse basic synthetase are isomorphous to those of the fully-
ligated mouse enzyme. All complexes have one subunit of a synthetase dimer in the 
asymmetric unit of the crystal. The stereochemistry of the refined models, as defined by the 
program PROCHECK, exceeds that usually observed for protein structures of comparable 
resolution. No residues lie in disallowed regions of the Ramachandran plot, and 90% of all 
residues are in the most favored regions. The average uncertainty in coordinates is 
approximately 0.3 À. Thermal parameters vary from 10-85, 5-100, 8-100, 12-100 and 
11-100 Â2 for the GDP/MgS04/£. coli, GDP/U2SO4/E coli, GDP/MgS04/mouse, 
GDP/LiS04/mouse and IMP/MgCb/mouse complexes, respectively. Regions of weak or 
absent electron density correspond to short segments of specific loops, described more 
completely below, and to residues preceding position 28 of the mouse basic isozyme. 
(Residues 1-30 of the mouse basic isozyme define an N-terminal leader sequence not present 
in the £. coli synthetase). The presence or absence of a poly-histidyl tag at the N-terminus of 
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the mouse basic synthetase had no effect on the formation of crystals, or on the structures of 
the resulting complexes (data not provided). 
Dynamic structural elements of adenylosuccinate synthetase, recognized from 
previous work, are the pre-Switch, Switch, IMP, GTP, Asp, and the Val loops (Fig. 1). 
Removing the above-named dynamic elements from consideration, all structures of the E. 
coli and mouse basic synthetases, save the IMP/MgCb/mouse complex, superimpose on their 
respective, fully-ligated complexes with root-mean-square deviations in Ca coordinates of 
less than 0.5 Â. IMP/ MgCh complex superimposes better on the ligand-free structure than 
on the fully-ligated complex (root-mean-square deviations in Ca coordinates of 0.5 Â versus 
1.3 A). Some of the structural elements named above, however, exhibit different 
conformational states, which arise evidently in response to a change in counter ion to the 
metal cation and/or the metal cation itself (Table II). Most notably, the Switch loop is in its 
ligated position in guanine nucleotide complexes with MgSOj and U2SO4, whereas in the 
presence of Mg(OAch, the same loop is in its ligand-free conformation. On the other hand, 
in IMP complexes the Switch loop is in its ligated conformation with Mg(OAc):, but 
becomes disordered in the presence of MgCh. What follows is a detailed account of the key 
structural features of each of the complexes, with emphasis on the role played by counter 
ions to the metal cation. Interactions involving the guanine nucleotide are essentially 
identical to those observed in fully-ligated complexes of the mouse muscle and E. coli 
synthetases (9,16), and hence, will not be described in detail here. 
GDP/MgSOj complex of the E. coli synthetase— All of the dynamic elements exist in their 
ligated conformations, except for the Asp loop (Table II). The Asp-loop shifts away from the 
active site by up to 5 À. The peptide link between Val273 and Gly274 of the Val loop rotates 
180° relative to its position in the fully ligated complex. (In the fully ligated complex, 
backbone carbonyl 273 hydrogen bonds with the 2-hydroxy 1 group of 6PIMP). Arg303 and 
Arg305 participate in none of the several hydrogen bonds observed in the fully ligated 
complex (8), and in fact, the side chain of Arg303 projects into the solvent. 
Omit electron density is consistent with bound GDP, Mg2* and two molecules of 
sulfate (Fig. 2). Coordinates for GDP and Mg2* are in exact agreement with those reported 
for the fully-ligated E coli synthetase (PDB accession label 1CGO). One sulfate anion binds 
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to the 5'-phosphoryl site of 6PIMP, whereas the other occupies the 6-phosphoryl site of 
6PIMP of the fully-ligated complex. Sulfate anions at the 5'- and 6-phosphoryl pockets of 
6PIMP each hydrogen bond with one water molecule, which occupy, respectively, the ribosyl 
and base regions of the 6PIMP pocket. The sulfate bound to the 6-phosphoryl site hydrogen 
bonds with the side chains of Lys 16, His4l, and Gln224, and backbone amides 13, 40, and 
224. Oxygen atoms from the side chain of Asp 13, backbone carbonyl 40, the a- and P-
phosphoryl groups of GDP and a water molecule coordinate the magnesium cation. The 
sulfate anion at the 5'-phosphoryl site of 6PIMP, hydrogen bonds with backbone amide 129 
and with the side chains of Asn38, Thrl29, Arg 143#, and Thr239. (The # symbol above 
designates a residue from the symmetry related monomer). The interaction of Thr 129 with 
this sulfate molecule may facilitate hydrogen bonds between backbone amides 126, 127 and 
128 and the side chain of Glu 118. The latter interactions evidently promote the ordered IMP 
loop as observed in the fully ligated complex of the synthetase. 
GDP/MgS04 complex of the mouse basic synthetase—As above, the pre-Switch, Switch, and 
GTP loops are in their ligated conformations and the Asp loop is in its ligand-free 
conformation. However, in contrast to the E. coli system, the IMP loop is only partially 
ordered and the Val loop is in its ligand-free conformation. Electron density is missing for 
the N-terminal half (residues 156-160) of the IMP loop. The side chain of Glu 149 (Glu 118 
in the £. coli enzyme) interacts with backbone amides 161 and 162, rather than 160, 161 and 
162 as observed in the fully ligated complex of the mouse synthetase (9) 
Omit electron density at the active site is consistent with bound GDP, Mg2* and two 
molecules of sulfate (Fig. 2). The interactions of the ligands above are basically identical to 
those described for the GDP/MgS04 complex of the £. coli enzyme. Arg335 (Arg303 of the 
£. coli synthetase) projects away from the active site, and Arg337 (Arg305 of the £. coli 
synthetase) does not hydrogen bond with the a-phosphoryl group of GDP. 
GDP/LizS04 complex of the E. coli synthetase— The Switch and GTP loops are in their 
ligated conformations, the Asp and Val loops are in their ligand-free conformations, and the 
IMP-loop is disordered entirely (Table II). The pre-Switch loop adopts a distinct 
conformational state, never seen before in other £. coli synthetase structures. Thus, compared 
to GDP/MgS04 complex or the fully ligated complex, the side chain of Asn38 and the 
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backbone atoms of residues 38-39 deviate from the usual ligated conformation by about 1 À. 
The Asp loop has a defined conformation, stabilized by crystal lattice contacts and identical 
to that seen in the AMP and hydantocidin 5'-phosphate complexes (20). GDP binds to the 
OTP pocket and a single sulfate molecule binds at the putative 3-carboxyl pocket of l-
aspartate, interacting with the side chains of Thr301 and Arg303, and backbone amides 300, 
301 and 302. No electron density is present either for a sulfate anion at the 5-phosphoryl 
site of IMP or for a metal at the Mg2+ site. Extending from the fi-phosphoryl group of GDP 
and partially occupying the 6-phosphoryl site of 6PIMP is electron density representing 
either a tightly bound water molecule or a y-phosphoryl group at partial occupancy. Largely 
because of this the side chain of His41 reorients and interacts with the P-phosphoryl group of 
GDP, the side chain of Gln224 is in an extended conformation, intruding into the binding 
pocket for the IMP base, and the side chain of Asp 13 moves from its usual position in Mg2+-
coordinated complexes to hydrogen bond with Arg305. The 5'- and 6-phosphoryl sites of 
6PIMP are open to sulfate anions, but evidently no binding occurs to either site in the 
absence of a coordinated Mg2+. 
The direct assignment of Li+ to electron density at a nominal resolution of 1.9 Â is 
implausible. A cluster of oxygen atoms with unacceptable non-bonded contacts (and perhaps 
coordinated to Li*) or the displacement of a water molecule of significance to the tertiary 
structure could infer a binding site for Li*. The water molecule that hydrogen bonds the 2'-
hydroxyl of GDP and backbone carbonyls 42 and 417 of the Switch and GTP loops, 
respectively, remains in place, however, and no set of atoms (oxygen or otherwise) exhibit 
non-bonded contacts of less than 2.5 Â. 
GDP/U2SO4 complex of the mouse muscle synthetase — The Switch and GTP loops are in 
their ligated conformations, the Asp and Val loops are in their ligand-free conformations, the 
IMP-loop is disordered entirely, and as in the E. coli system, the pre-Switch loop adopts a 
distinct conformational state (Table II). GDP binds at its usual site but the 5'-phosphoryl and 
6-phosphoryl sites of 6PIMP are empty (Fig. 3). Instead, a single sulfate molecule at high 
occupancy interacts with the side chains of Asn68, Asn256 and Thr271, and with backbone 
amides 66, 67 and 68, and is 4 and 7 Â removed from the 5'- and 6-phosphoryl sites of 
6PIMP, respectively. Most of the interactions come from the pre-Switch loop (residues 
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65-70), the conformational state of which differs from that observed in the ligand-free, 
6PIMP-ligated, and AMP-ligated synthetases (Fig. 4). The sulfate molecule displaces the 
side chain of Asn68 into the space normally occupied by the Thrl63 of the IMP loop, and 
perhaps blocks the transition to an ordered conformation for that loop. A diffuse sphere of 
electron density is in proximity to the Asp loop and may represent a weakly bound sulfate 
molecule. As in the GDF/LiiSO-j complex of the E. coli synthetase, no clear evidence 
supports the direct binding of Li* to the complex. 
IMP/MgCh complex of the mouse basic synthetase— The GTP, Asp and Val loops are in 
their ligand-free conformations (Table II). The conformation of the pre-Switch loop 
approximates that of the non-productive IMP complex and AMP complex of the mouse-
muscle synthetase (9.33). The Switch loop is completely disordered, and the IMP loop is 
partially disordered. In all previous structures the Switch loop has adopted either the ligated 
or the ligand-free conformation, but here patches of electron density suggest the loop may be 
in both conformations. Omit electron density reveals a molecule of IMP bound 
nonproductively (base towards the Asp loop), with interactions identical to those of the IMP 
molecule at chain B of the IMP/Mg(OAch complex (9). Weak electron density at the pocket 
for the productively bound base moiety of IMP suggests a minor fraction of productive IMP 
association. The dual binding modes for IMP is probably correlated with extensive disorder 
in the Switch loop and helix H2 (residues 111-119). Some of the residues of helix H2 
hydrogen bond with the Switch loop in its ligand-free conformation (21). Electron density is 
missing for the N-terminal portion of the IMP loop (residues 151-159), but the C-terminal 
portion, which hydrogen bonds with Glu 149 and the 5 -phosphoryl group of IMP, is ordered. 
Weak electron density is associated with the (3-phosphoryl site of the GTP pocket that 
probably comes from a bound chloride anion. 
Discussion 
A quick glance at Table II reveals the sensitivity of adenylosuccinate synthetase to relatively 
minor changes in the conditions of crystallization. Yet the manifold of conformations now 
available for the E. coli and mouse muscle synthetases, suggest important factors governing 
conformational change that may hold for the entire synthetase family. 
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The IMP-induced movement of the Switch loop from its ligand-free to ligated 
conformation requires an additional set of interactions at the P-phosphoryl site of the GTP 
pocket. In the IMP/Mg(OAc)2 complex (9), IMP binds productively at chain A and an 
acetate molecule occupies the ^-phosphoryl site of the guanine nucleotide pocket. The 
Switch loop is in its ligated conformation. Substitution of Mg(OAc): with MgCh introduces 
significant disorder throughout the active site. A chloride ion binds to the ^-phosphoryl site 
of the GTP pocket, but hydrogen bonds involving Cl~ are weaker than those of acetate. 
Hence, the substitution of Cl~ for acetate at the ^-phosphoryl site destabilizes the ligated 
conformer of Switch loop relative to its ligand-free conformation. 
The binding of anions and Mg2+ to the active site in the presence of GDP is a more 
complex phenomenon than for IMP. Firstly, the binding of sulfate anions to the 5'- and 6-
phosphoryl pockets of 6PIMP, occurs only in the presence of Mg2+. Sulfate anions, for 
instance, occupy the 5*- and 6-phosphoryl pockets of 6PIMP in GDP/MgSOa complexes, but 
not so for GDP/U2SO4 complexes. The sulfate molecule at the 6-phosphoryl pocket 
coordinates directly to the active-site Mg2+, and thus the interdependency of Mg2>-sulfate 
association here is of little surprise; however, the binding of a sulfate molecule to the 5'-
phosphoryl pocket also seems to depend on the existence of sulfate-Mg2* at the 6-phosphoryl 
pocket. Secondly, acetate molecules do not bind to the 5'- or 6-phosphoryl pockets of 
6PIMP, nor does Mg2+ bind specifically to the active site in the GDP/Mg(OAc)i complex of 
the mouse muscle synthetase (9). Hence, the structural data are consistent with 
thermodynamic coupling between the binding of tetrahedral anions to the 5'- and 6-
phosphoryl pockets of 6PIMP and the binding of Mg2+ to a GDP-ligated active site 
The above observations undermine an assumption built into a kinetic model regarding 
the interaction of Mg2+ with the synthetase. Kang et al. (4) assume GTP binds to the 
synthetase as a GTP/Mg2* complex, whereas structural data support the binding of Mg2+ to 
its functional site only in the presence of bound GTP and IMP. Hence, Mg2* cooperativity in 
the initial velocity kinetics of the synthetase, observed under conditions that may not be 
saturating with respect to the concentrations of IMP and/or GTP, could be a consequence of 
binding synergism between Mg2*, IMP, and GTP. On the other hand, the structural data are 
in excellent agreement with a study in kinetic isotope exchange at equilibrium (6). The 
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exchange data are consistent with a strongly biased kinetic pathway in which the binding of 
GTP and IMP precedes the association of L-aspartate. Crystallographic results here provide a 
structural basis for the preferred binding sequence: Mg2+ has no place to bind until both IMP 
and GTP are in place, and as the a-carboxylate of L-aspartate coordinates directly to the 
active site Mg2+, the amino acid must wait for the metal cation. The preferred binding 
sequence for ligands to the synthetase (first IMP/GTP, then Mg2+, and last L-aspartate) would 
also guard against non-productive hydrolysis of GTP. 
Prade et al. (24) observed the Switch loops of two plant synthetases in their ligated 
conformations in the presence of GDP alone. The ligated conformer was attributed to a 
hydrogen bond between GDP and Tyr61, a residue common to the plant synthetases, but not 
conserved in the mouse muscle and £. coli synthetases. Although data here cannot discount 
the stabilizing effect of the tyrosine-GDP hydrogen bond, that hydrogen bond may not be 
responsible for the ligated conformation of the Switch loop in the plant synthetases. Under 
the same conditions of crystallization the mouse-muscle and £. coli synthetases also have 
ligated Switch loops. Evidently, the sulfate anion does not contribute to the ligated 
conformation: Bound sulfate molecules are not reported in the plant synthetase structures, 
and sulfate molecules in the GDP/LiiSO^ complexes of the mouse muscle and £. coli 
synthetases bind to different loci. Furthermore, complexes of both £. coli and mouse-muscle 
synthetases with GDP, in the presence of either Na(acetate) or Li(acetate), also have the 
Switch loop in the ligated conformation (Iancu and Honzatko, unpublished). Hence, the 
Switch loops of all synthetases studied thus far exhibit the same conformational response to 
GDP/U2SO4. 
Two differences are evident at least between the mouse muscle and £. coli 
synthetases: The pre-Switch and IMP loops of each system respond differently to bound 
sulfate molecules. Conformational flexibility in the pre-Switch loop of the mouse-muscle 
synthetase in the GDP/U2SO4 complex evidently facilitates the binding of a sulfate molecule, 
as Asn68 and backbone amides of the pre-Switch loop change conformation to optimize 
hydrogen bonding with the ligand. The pre-Switch loop of the £. coli synthetase, which 
exhibits less conformational variability does not bind a sulfate molecule. Iancu et al. (21) 
have suggested a connection between the conformational variations in the pre-Switch loop of 
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the mouse muscle system and differences in the recognition of IMP analogues (34,35) and 
fructose 1,6-bisphosphate (1,10) amongst synthetases. For the E. coli synthetase with its 
relatively short IMP-loop, a sulfate anion at the 5'-phosphoryl pocket puts the loop into its 
ligated conformation, whereas for the mouse muscle isozyme, only the C-terminal half of the 
IMP loop is ordered. Completely ordered IMP-loops appear in fully ligated complexes of the 
mouse muscle enzyme, probably because of interactions involving the ribosyl group of IMP. 
The 2-hydroxyI group of IMP hydrogen bonds with backbone carbonyl 305 (Val loop) 
allowing backbone amide 307 to hydrogen bond with backbone carbonyl 160 (IMP loop). 
Hence, the ligated conformation of the extended IMP loop of the mouse muscle system may 
require interactions at and the ribosyl pocket, as well as the 5'-phosphoryl site. 
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Table I. Statistics of data collection and refinement. 
GDP/MgSOj gdp/mrso4 GDP/U2SO4 GDP/U2SO4 IMP/MgCh 
E, coli mouse mouse E, coli mouse 
Data reduction 
Space group P3,2| P432,2 P432,2 P4,2,2 P432,2 
Unit cell parameters (A) ti=/>=80,l9, «=Z>=70.26, a=b=70.55, «=/>=69.37, a=b=70.11, 
(-158.75 c= 198.71 c=198.30 (-198.07 c=200.41 
Resolution limits (A) 52.7-2.2 49.7-2.3 100-2.5 65.5-1.9 50.0-2.3 
No. of reflections 189,525 164,069 155,194 398,168 170,653 
No of unique reflections 31,070 23,041 18,432 36,319 23,801 
Completeness of data (%) 
Overall 99.0 99.7 99.4 92.7 98.3 
Last shella 92.4 98.6 99.4 50.4 98.4 
Rmergeb 
Overall 0.056 0.071 0.048 0.047 0.041 
Last shella 0.253 0.316 0.472 0.200 0.295 
'Resolution range is approximately 2.3-2.2 A for the E, coli GDP/MgS04 complex, 2.4 -2.3 A for GDP/MgS04 and 
IMP/MgCh complexes of mouse muscle synthetase, 2.4-2.5 A and 1.9-2.0 A for the GDP/U2SO4 complex of the mouse 
muscle and E. coli synthetases, respectively. 
bRmcige = XjIi|lij-<Ij>|/IiXj lij, where i runs over multiple observations of the same intensity and j runs over 
crystallographically unique intensities. 
Table 1 (continued) 
GDP/MhS04 GDP/MgSOj GDP/LiiSOj GDP/LiiSOj IMP/MgCh 
E, coli mouse mouse E. coli mouse 
Refinement 
Number of reflectionsc 30,632 22,650 17,205 35,879 22,722 
Number of atoms 3321 3348 3353 3277 3353 
Number of solvent sites 123 95 57 238 73 
Rd/Rfreec .245/.2S5 .227/.260 .222/283 .212/241 .240/286 
Mean B for protein (A2) 
Main chain 44 34 42 21 39 
Side chain 46 36 45 23 43 
Root mean square 
deviations 
Bond lengths (À) 0.007 0.006 0.006 0.006 .006 
Bond angles (°) 1.3 1.2 1.2 I . I  1.3 
Dihedral angles (°) 22.9 23.1 23.2 21.1 22.8 
Improper dihedral 
angles (°) 0.98 0.77 0.83 0.68 0.93 
CAII unique data in the resolution range from 10 À to the highest resolution of each complex, 
dR-factor = I||Fobs|-|Fca,c||/X|Fobs|, |Fobs|>0. 
'R-factor based upon 10% of the data randomly culled and not used in the refinement. 
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Table II. Conformational status of six dynamic loops of the recombinant mouse basic 
and E. coli synthetases. The symbols U and L represent loop conformations observed in the 
ligand-free and fully ligated synthetases, respectively. The symbol P stands for partially 
ligated conformations and the symbol D represents a state of disorder for which no 
assignment of conformation is possible due to weak or absent electron density. Subtle 
variations in L conformations are explained by footnotes to this table. Loops are defined in 
Fig. 1. 
Name of Complex Name of loop 
Pre-
Switch 
Switch IMP Val Asp GTP 
IMP/Mg( acetate): L L L L L L 
E. coif" 
IMP/Mg(acetateh L L L L L L 
Chain A, Mouseb 
IMP/Mg(acetate)2 Ld L L U U L 
Chain B Mouse6 
IMP/MgClz Mouse L D P U U U 
GDP/Mg( acetate): U U D U u L 
Mousec 
GDP/MgSO.* Mouse L L P U u L 
GDPZMgS04 E. coli L L L Le u L 
GDP/Li%S04 Mouse Lf L D U u L 
GDP/Li2S04 E. coli Lr L D u p L 
aPDB entry 1KJX (22). 
bPDB entry 1IWE(9). 
LPDB entry 1LON (9). 
dThe backbone conformation of residues 68 and 69 differ from the ligated conformer, but 
residues 65-67 are in the ligated conformation. This conformational variation is observed 
in AMP-ligated active sites of the mouse basic isozyme (33). 
eThe peptide linkage between residues 273 and 274 reorients by a rotation of approximately 
180° relative to the ligated conformation. 
fThe backbone conformation of residues 68 and 69 differ from the ligated conformer, but 
residues 65-67 are in the ligated conformation (see Fig.4) 
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pre-Switch | loop .prc-Switch L loop 
Switch 
loop 
Switch 
lixip 
Fig. 1. Stereo view of a synthetase monomer in its fully ligated conformation. Bold lines 
represent the pre-Switch (residues 65-69 and 35-39 in mouse basic and E. coli synthetase, 
respectively). Switch (residues 70-83 and 40-53 in mouse basic and £. coli synthetase, 
respectively), IMP (residues 152-165 and 120-130 in mouse basic and E. coli synthetase, 
respectively). Val (residues 304-310 and 272-278 in mouse mouse basic and £. coli 
synthetase, respectively), Asp (residues 330-336 and 298-304 in mouse mouse basic and E. 
coli synthetase, respectively) and GTP (residues 448-452 and 417-421 in mouse basic and £. 
coli synthetase, respectively) loops. Ligands (labeled GDP, 6PIMP, and HAD for hadacidin) 
are in wire-frame representation. A filled circle (labeled Mg) represents the site of Mg2+ 
binding. This figure was drawn with MOLSCRIPT (36). 
Fig.2 Stereoview of the GDP/MgSCKi complexes of E. coli (top) and mouse basic 
(bottom) synthetases. Electron density is from an omit map (coefficients of 2F0bs-Fcaic, a^c 
phases) contoured at 3a using a cutoff radius of 1 Â. Dashed lines represent donor-acceptor 
interactions and coordinate bonds to the Mg2+. Only the protein interactions with the sulfate 
molecules and Mg2+ are shown. 
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Fig.3 Stereoview of the GDP/L1SO4 complex of mouse-muscle synthetase. One molecule 
of GDP binds at the GTP (GDP) site and one molecule of sulfate binds at a new site in 
proximity of the pre-Switch loop. Electron density is from an omit map (coefficients of 
2Fobs*Fcale» ««le phases) contoured at 3a using a cutoff radius of 1 Â. Dashed lines represent 
donor-acceptor interactions. Only the protein interactions with the sulfate molecule are 
shown. 
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Ala69 
Asn68 
Asn67 
Ala69 
Asn67 
Fig. 4. Slereoview of the superposition of the pre-Switch loops from different complexes 
of mouse-muscle synthetase. Thinnest lines represent the conformation in fully ligated 
complexes (9) or GDP/MgSCX complex. Thin lines represent the conformation in the AMP 
complex or chain B of IMP/Mg(acetate>2 complex (9,33). Bold lines represent the 
conformation in GDP/LiSO* complex. 
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chapter 6. general conclusions 
Summary 
In order to better understand the differences in ligand recognition amongst 
adenylosuccinate synthetases, a comprehensive structural study of the mouse basic isozyme 
was carried out by using x-ray crystallography techniques. The ligand-free structure of the 
mouse-muscle synthetase has an active site conformation different from that of the £. coli 
synthetase. Residues of the pre-Switch loop (65-68) adopt a new conformation that would 
sterically preclude IMP from binding productively to the active site. IMP has two modes of 
binding to the IMP pocket, only one of which is productive. In addition, IMP also binds to 
the GTP pocket. Substrate inhibition by IMP, a property specific to the basic isozyme, may 
be related to the unusual IMP recognition described above. Ligand-induced conformational 
changes at the active site, were explored in structures of partial ligation with either IMP or 
GDP (GTP), in the presence of different types of anions and cations. IMP requires a bound 
anion to the (3-phosphoryl pocket of GTP in order to organize the active site. Furthermore. 
Mg2+ may bind preferentially to an active site ligated by both GDP (or GTP) and IMP, and 
does not bind as a stoichiometric complex of Mg2VGTP. These rules are probably valid for 
all synthetases, as structures of £. coli, plants and mouse-muscle synthetases comply with 
them. The combination of GTP and IMP results in the formation of a stable complex of 6-
phosphoryl-IMP and GDP. in the presence or absence of hadacidin, a tight-binding analogue 
of l-aspartate. In accordance with the general chemical mechanism of the synthetase, the 
conformation of the mouse basic isozyme and the E. coli synthetase in their complexes with 
GDP, 6-phosphoryl-IMP and hadacidin are nearly identical. The complex of 
adenylosuccinate/GDP/Mg2"7sulfate, the first structure of an adenylosuccinate-bound 
synthetase, reveals significant geometric distortions, tight non-bonded contacts, and a 
probable state of protonation for adenylosuccinate consistent with the formation of a C-6 
purine cation. The reaction coordinate for the formation of adenylosuccinate from 6PIMP 
and L-aspartate is a 30° movement of the purine ring. The structural data imply a precisely 
tuned set of interactions that allow Mg2> to modulate the acid/base properties of Asp43 (Asp13 
in the £. coli synthetase) in the sequence of reactions catalyzed by the synthetase. 
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Adenylosuccinate synthetase is subject to feedback inhibition by AMP, but crystallographic 
complexes of the mouse-muscle synthetase with AMP infer mechanisms of inhibition that 
involve synergistic ligand combinations. Thus, AMP alone adopts the productive binding 
mode of IMP, and yet stabilizes the active site in a conformation that favors the binding of 
Mg2+-IMP to the GTP pocket. In exhaustively exercised muscle, IMP concentrations rise, so 
that AMP/IMP binding synergism, if it were to occur, could limit synthetase activity in 
muscle under conditions of vigorous exercise. On the other hand, AMP, in the presence of 
GDP. orthophosphate and Mg2+, adopts the binding mode of adenylosuccinate. Hence, 
depending on the state of active site ligation, AMP behaves as an analogue of IMP or as an 
analogue of adenylosuccinate. 
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